var title_f13_5_13392="Hemiretinal vein occlusion";
var content_f13_5_13392=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hemiretinal vein occlusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Intraretinal hemorrhages in half of the retina on funduscopic examination.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13392=[""].join("\n");
var outline_f13_5_13392=null;
var title_f13_5_13393="Patient information: Histoplasmosis (The Basics)";
var content_f13_5_13393=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Histoplasmosis (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H629377813\">",
"      <span class=\"h1\">",
"       What is histoplasmosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Histoplasmosis is an infection caused by a fungus. It does not cause symptoms in most people. When it does cause symptoms, the symptoms can include fever, headache, muscle aches, cough, and chest pain when taking a deep breath.",
"     </p>",
"     <p>",
"      The fungus that causes histoplasmosis lives in soil that contains bird or bat droppings. The fungus can travel in dust specks that you can breathe in. Most people who get histoplasmosis get better without treatment.",
"     </p>",
"     <p>",
"      The fungus that causes histoplasmosis is found in:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Midwestern and central states in the United States, along the Ohio and Mississippi River valleys",
"       </li>",
"       <li>",
"        Some states along the east coast of the United States",
"       </li>",
"       <li>",
"        Mexico and Central and South America",
"       </li>",
"       <li>",
"        Parts of eastern and southern Europe, Africa, eastern Asia, and Australia",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most people living in areas where the histoplasmosis fungus is found never get sick. But infections can happen in people who have trouble fighting infection and in people who are exposed to a large amount of the fungus, such as farm or construction workers or people who visit caves (called &ldquo;spelunkers&rdquo;). Histoplasmosis tends to affect the lungs. In rare cases, the infection can spread throughout the body, especially in people whose immune system is not working well.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H629377828\">",
"      <span class=\"h1\">",
"       What are the symptoms of histoplasmosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Often histoplasmosis causes no symptoms. When symptoms do occur, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Chills",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Muscle aches",
"       </li>",
"       <li>",
"        Loss of appetite",
"       </li>",
"       <li>",
"        Cough",
"       </li>",
"       <li>",
"        Chest pain when taking a deep breath",
"       </li>",
"       <li>",
"        Aching joints (sometimes with a skin rash)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H629377843\">",
"      <span class=\"h1\">",
"       Is there a test for histoplasmosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If your doctor or nurse suspects you have histoplasmosis, he or she might do tests to look for signs of the infection. These can include blood or urine tests and tests on a sample of mucus that you cough up. There is also a test that involves putting a tube into your lungs to get a sample of fluid or tissue.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H629377858\">",
"      <span class=\"h1\">",
"       How is histoplasmosis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Histoplasmosis does not always need to be treated. If you are fairly healthy, your doctor or nurse might want to wait and see if you can fight off the infection on your own. He or she will want to see you every 2 to 4 weeks to make sure you are getting better.",
"     </p>",
"     <p>",
"      For people who do need to be treated, there are medicines called &ldquo;anti-fungals&rdquo; that can kill the fungus that causes histoplasmosis. Some people must take them for months or even years. This includes:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        People with HIV infection (or AIDS)",
"       </li>",
"       <li>",
"        People who have had an organ transplant",
"       </li>",
"       <li>",
"        People with cancers of the blood",
"       </li>",
"       <li>",
"        People who take medicines called &ldquo;steroids&rdquo; or other medicines that partly &ldquo;turn off&rdquo; immune system",
"       </li>",
"       <li>",
"        Pregnant women",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H629377873\">",
"      <span class=\"h1\">",
"       Can histoplasmosis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you live in an area where histoplasmosis occurs, you can reduce your chances of getting the infection by doing the following:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Do not disturb the soil in areas where birds roost",
"       </li>",
"       <li>",
"        Do not visit areas where buildings have been demolished",
"       </li>",
"       <li>",
"        Do not explore caves",
"       </li>",
"      </ul>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?13/5/13393?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87577 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-84F2B57B49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13393=[""].join("\n");
var outline_f13_5_13393=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629377813\">",
"      What is histoplasmosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629377828\">",
"      What are the symptoms of histoplasmosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629377843\">",
"      Is there a test for histoplasmosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629377858\">",
"      How is histoplasmosis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H629377873\">",
"      Can histoplasmosis be prevented?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_5_13394="Patient information: Erythema infectiosum (fifth disease) (The Basics )";
var content_f13_5_13394=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83162\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/9/28831\">",
"         Slapped cheek rash",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/6/12384\">",
"          Rash in erythema infectiosum",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/39/33395\">",
"         Patient information: Avoiding infections in pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/40/40578\">",
"         Patient information: Fever in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?42/52/43843\">",
"         Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Erythema infectiosum (fifth disease) (The Basics )",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/erythema-infectiosum-fifth-disease-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H18905262\">",
"      <span class=\"h1\">",
"       What is erythema infectiosum?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Erythema infectiosum is an infection that causes a rash, fever, and other symptoms. It is caused by a virus called &ldquo;human parvovirus.&rdquo; Another name for erythema infectiosum is &ldquo;fifth disease.&rdquo;",
"     </p>",
"     <p>",
"      Fifth disease is common in children. Adults can also get it. If a pregnant woman gets fifth disease, it can be dangerous for her unborn baby.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905277\">",
"      <span class=\"h1\">",
"       What are the symptoms of fifth disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Many people with fifth disease have no symptoms or only mild symptoms. Most people feel better in a few weeks.",
"     </p>",
"     <p>",
"      When symptoms do occur, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Sore throat",
"       </li>",
"       <li>",
"        Itching",
"       </li>",
"       <li>",
"        Cough",
"       </li>",
"       <li>",
"        Upset stomach &ndash; With diarrhea, nausea, and vomiting",
"       </li>",
"       <li>",
"        Sneezing",
"       </li>",
"       <li>",
"        Conjunctivitis (also called &ldquo;pinkeye&rdquo;) &ndash; This is an eye infection or irritation.",
"       </li>",
"       <li>",
"        Muscle aches &nbsp;",
"       </li>",
"       <li>",
"        Joint aches &ndash; These are more common in adults who get fifth disease. Children do not get them as often.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      The first symptoms last 2 to 5 days. After that, symptoms can include: &nbsp;",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Rash on the face &ndash; Often called a &ldquo;slapped cheek&rdquo; rash, this rash makes a child&rsquo;s cheek looks bright red, as if someone just slapped it (",
"        <a class=\"graphic graphic_picture graphicRef83120 \" href=\"UTD.htm?28/9/28831\">",
"         picture 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Rash on the chest, back, arms, and legs &ndash; This usually shows up after the face rash. The rash makes a pattern that looks like lace (",
"        <a class=\"graphic graphic_picture graphicRef83122 \" href=\"UTD.htm?12/6/12384\">",
"         picture 2",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Joint pain &ndash; Usually in hands, wrists, knees, and feet. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Children often feel better by the time they get a rash. Sometimes, the rash comes back after it goes away. Sunlight, temperature changes, exercise, or stress can make it come back.",
"     </p>",
"     <p>",
"      People with certain medical conditions can get sicker with fifth disease than other people. They include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        People who have problems with the body&rsquo;s infection-fighting system, called the &ldquo;immune system.&rdquo;",
"       </li>",
"       <li>",
"        People who have certain conditions that affect red blood cells, such as sickle cell disease or thalassemia.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905292\">",
"      <span class=\"h1\">",
"       Is there a test for fifth disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A doctor or nurse can usually tell if someone has it by learning about the symptoms and doing an exam. If there is any doubt, he or she can order a blood test for the virus that causes fifth disease.",
"     </p>",
"     <p>",
"      If you are pregnant and have symptoms of fifth disease, or are around someone who has it, tell your doctor or nurse right away. He or she can order a blood test to see if you have the infection. Your doctor or nurse can also do tests to see if your unborn baby has the infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905307\">",
"      <span class=\"h1\">",
"       Should my child see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your child has an immune or blood disorder and has symptoms of fifth disease, see the doctor or nurse.",
"     </p>",
"     <p>",
"      If you or your child has symptoms for more than a month, see your doctor or nurse. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905324\">",
"      <span class=\"h1\">",
"       How is fifth disease treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people with fifth disease get better without treatment. If your child has itching or joint pain, the doctor or nurse might recommend medicine to help your child feel better. For example, the doctor might recommend",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"       ibuprofen",
"      </a>",
"      &nbsp;(sample brand names: Advil&reg;, Motrin&reg;) to treat pain. &nbsp;",
"     </p>",
"     <p>",
"      So far, doctors do not have a good medicine to treat the virus that causes fifth disease. Antibiotics DO NOT WORK on fifth disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905338\">",
"      <span class=\"h1\">",
"       Can fifth disease be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can lower your chances of getting fifth disease by:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Washing your hands often with soap and water, or using an alcohol hand rub. Teach your children to do the same.",
"       </li>",
"       <li>",
"        Not sharing food and drinks with other people.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905353\">",
"      <span class=\"h1\">",
"       What if I am pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you are pregnant and were around someone with the virus that causes fifth disease, ask your doctor or nurse about your risk of infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18905368\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=see_link\">",
"       Patient information: Avoiding infections in pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=see_link\">",
"       Patient information: Fever in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=see_link\">",
"       Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?13/5/13394?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83162 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-8539BEA455-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13394=[""].join("\n");
var outline_f13_5_13394=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905262\">",
"      What is erythema infectiosum?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905277\">",
"      What are the symptoms of fifth disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905292\">",
"      Is there a test for fifth disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905307\">",
"      Should my child see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905324\">",
"      How is fifth disease treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905338\">",
"      Can fifth disease be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905353\">",
"      What if I am pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18905368\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83162\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/9/28831\">",
"      Slapped cheek rash",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/6/12384\">",
"       Rash in erythema infectiosum",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_5_13395="Types of surgical needles";
var content_f13_5_13395=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F54201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F54201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Types of surgical needles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13395=[""].join("\n");
var outline_f13_5_13395=null;
var title_f13_5_13396="Maculopapular sarcoidosis";
var content_f13_5_13396=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F66626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F66626&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Maculopapular sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 287px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Maculopapular sarcoidosis. Typical lesion consisting of small papules arising from a slightly indurated skin-colored patch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13396=[""].join("\n");
var outline_f13_5_13396=null;
var title_f13_5_13397="Balamuthia skin lesions";
var content_f13_5_13397=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F88059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F88059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spectrum of skin lesions in patients infected with Balamuthia mandrillaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 439px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) A young boy with a classical plaque lesion on the central face.",
"    <br/>",
"    (Panel B) An adult female with a similar lesion over the nose.",
"    <br/>",
"    (Panel C) An older patient with a plaque over the nose.",
"    <br/>",
"    (Panel D) A young boy with an annular plaque behind the knee (after the face, the second most common location).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13397=[""].join("\n");
var outline_f13_5_13397=null;
var title_f13_5_13398="Chronic kidney disease";
var content_f13_5_13398=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Chronic kidney disease (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/5/13398/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13398/contributors\" id=\"au7217\">",
"       Jeffrey S Berns, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/5/13398/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13398/contributors\" id=\"se6134\">",
"       Gary C Curhan, MD, ScD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/5/13398/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13398/contributors\" id=\"de1856\">",
"       Alice M Sheridan, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?13/5/13398?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      CHRONIC KIDNEY DISEASE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Chronic kidney disease (CKD, also called kidney failure) is a condition in which the kidneys lose the ability to remove waste and excess water from the bloodstream. As waste and fluids accumulate, other body systems are affected, potentially leading to complications.",
"    </p>",
"    <p>",
"     The most common causes of chronic kidney disease are diabetes and high blood pressure. In the early stages of CKD, there are no obvious symptoms. The disease can progress to complete kidney failure, also called end stage renal disease. This occurs when kidney function has worsened to the point that dialysis or kidney transplantation is required to maintain life.",
"    </p>",
"    <p>",
"     The main goal of treatment is to",
"     <strong>",
"      prevent",
"     </strong>",
"     progression of CKD to complete kidney failure. The best way to do this is to diagnose and control the underlying cause.",
"    </p>",
"    <p>",
"     The symptoms, evaluation, and management of chronic kidney disease will be reviewed here. Kidney transplantation, peritoneal dialysis, and hemodialysis are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/26/9635?source=see_link\">",
"      \"Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=see_link\">",
"      \"Patient information: Hemodialysis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      NORMAL KIDNEY FUNCTION",
"     </span>",
"    </p>",
"    <p>",
"     A brief overview of normal kidney function can help in the understanding of chronic kidney disease. The kidneys function to remove wastes and excess water from the blood. These wastes and fluids are combined to form urine (",
"     <a class=\"graphic graphic_figure graphicRef80336 \" href=\"UTD.htm?3/35/3634\">",
"      figure 1",
"     </a>",
"     ). Many vital body functions are dependent upon the proper functioning of the kidneys.",
"    </p>",
"    <p>",
"     In order for this filtering process to occur properly, the blood pressure and blood flow to the kidneys must be adequate. If the arteries leading to the kidney are diseased, the filtering process will be affected. The nephrons (",
"     <a class=\"graphic graphic_figure graphicRef82497 \" href=\"UTD.htm?5/10/5286\">",
"      figure 2",
"     </a>",
"     ), including the glomeruli and the tubules, must be healthy, and the path from the nephron to the urethra (",
"     <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"      figure 3",
"     </a>",
"     ) must not be blocked.",
"    </p>",
"    <p>",
"     When the kidney filters are working properly, the result is a proper balance of fluids and chemicals in the body. If an imbalance occurs, many critical bodily functions can be affected, possibly producing symptoms associated with kidney disease (see",
"     <a class=\"local\" href=\"#H4\">",
"      'Chronic kidney disease complications'",
"     </a>",
"     below).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CHRONIC KIDNEY DISEASE RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     A number of disorders can increase the risk of developing chronic kidney disease, including:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Diabetes mellitus",
"      </li>",
"      <li>",
"       High blood pressure",
"      </li>",
"      <li>",
"       Chronic glomerulonephritis (inflammation of the glomeruli), (see",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=see_link\">",
"        \"Patient information: Glomerular disease overview (Beyond the Basics)\"",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Polycystic kidney disease (cysts in the kidneys), (see",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?37/24/38277?source=see_link\">",
"        \"Patient information: Polycystic kidney disease (Beyond the Basics)\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       A family history of kidney disease",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      CHRONIC KIDNEY DISEASE COMPLICATIONS",
"     </span>",
"    </p>",
"    <p>",
"     Most people with chronic kidney disease do not have symptoms until the kidney function is severely impaired. The problem is often discovered when blood or urine tests, done for other reasons, show one or more of the abnormalities discussed above.",
"    </p>",
"    <p>",
"     Even when kidney failure is advanced, most people still make a normal or near-normal amount of urine; this is sometimes confusing. Urine is being formed but it does not contain sufficient amounts of the body's waste products.",
"    </p>",
"    <p>",
"     With advanced kidney disease, you may develop edema (swelling of the feet, ankles, or legs), of appetite, increased sleepiness, nausea, vomiting, confusion and difficulty thinking. Patients often develop high blood pressure, blood chemistry (electrolyte) abnormalities, anemia (a decrease in red blood cells, which can cause fatigue and other symptoms), and bone disease. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/53/32594?source=see_link\">",
"      \"Patient information: Edema (swelling) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Uremia",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with advanced kidney failure may develop a group of symptoms referred to as",
"     <strong>",
"      uremia",
"     </strong>",
"     . The symptoms of uremia include loss of appetite, nausea, vomiting, swelling around the heart, nerve problems, and changes in mental status, including drowsiness, seizures, or coma.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      EVALUATION AND DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     A healthcare provider may use several tests to diagnose chronic kidney disease and determine if there is a treatable underlying cause. These include the following:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Kidney function tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;The glomerular filtration rate (GFR) gives an approximate measure of the number of functioning nephrons. GFR is used to monitor the severity of kidney impairment. The most common way to estimate the GFR in adults is by measuring the creatinine level in the blood stream and then using this number to calculate an estimated GFR level. This GFR level is often shown on routine blood chemistry lab reports that your doctor obtains.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A reduction in GFR implies either worsening of the underlying kidney disease or the development of another, occasionally reversible kidney problem.",
"      </li>",
"      <li>",
"       An increase in GFR, on the other hand, indicates improvement in kidney function.",
"      </li>",
"      <li>",
"       A stable GFR in people with chronic kidney disease implies stable disease.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Urine tests",
"     </span>",
"     &nbsp;&mdash;&nbsp;The presence of albumin or protein in the urine (called albuminuria or proteinuria) is a marker of kidney disease. Even small amounts of albumin in the urine, called microalbuminuria, may be an early sign of chronic kidney disease in some people, particularly those with diabetes and high blood pressure. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/35/15921?source=see_link\">",
"      \"Patient information: Protein in the urine (proteinuria) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Imaging studies",
"     </span>",
"     &nbsp;&mdash;&nbsp;Imaging tests (such as CT or ultrasound) may be recommended to determine if there are any obstructions (blockages) of the urinary tract, kidney stones, or other abnormalities. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/53/28499?source=see_link\">",
"      \"Patient information: Kidney stones in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Kidney biopsy",
"     </span>",
"     &nbsp;&mdash;&nbsp;In a kidney biopsy, a small piece of kidney tissue is removed and examined under a microscope. The biopsy helps to identify abnormalities in kidney tissue that may be the cause of kidney diseases. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/14/30944?source=see_link\">",
"      \"Patient information: Renal (kidney) biopsy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      CHRONIC KIDNEY DISEASE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The first step in the treatment of chronic kidney disease is to determine the underlying cause. Some causes are reversible, including use of medications that impair kidney function, blockage in the urinary tract, or decreased blood flow to the kidneys. Treatment of reversible causes may prevent CKD from worsening.",
"    </p>",
"    <p>",
"     Research has shown that management of chronic kidney disease is best done with the assistance of a nephrologist, a doctor who specializes in kidney diseases. Early referral to a nephrologist decreases the chance of developing complications associated with chronic kidney disease.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Hypertension",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hypertension, or high blood pressure, is present in 80 to 85 percent of people with chronic kidney disease. Maintaining good blood pressure control is the most important goal for trying to slow progression of CKD. Taking a medication called an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) reduces blood pressure and levels of protein in the urine, and is thought to slow the progression of chronic kidney disease to a greater extent than some of the other medicines used to treat high blood pressure.",
"    </p>",
"    <p>",
"     Sometimes, a diuretic (water pill) or other medication is also added. You may be asked to monitor your blood pressure at home to be sure that your blood pressure is well controlled. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=see_link\">",
"      \"Patient information: High blood pressure treatment in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Anemia",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with chronic kidney disease are at risk for anemia. This occurs because improperly functioning kidneys produce reduced amounts of a substance called erythropoietin. Anemia can lead to fatigue and other complications.",
"    </p>",
"    <p>",
"     Selected patients can be treated with drugs that stimulate production of red blood cells. You or a family member can inject these drugs at home. In some cases, iron supplements are also prescribed. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/18/41257?source=see_link\">",
"      \"Anemia of chronic kidney disease: Target hemoglobin/hematocrit for patients treated with erythropoietic agents\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Dietary changes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Changes in your diet may be recommended to control or prevent some of the complications of chronic kidney disease; most important is salt restriction to help control the blood pressure.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h3\">",
"      Protein restriction",
"     </span>",
"     &nbsp;&mdash;&nbsp;Restricting protein in the diet may slow the progression of chronic kidney disease, although it is not clear if the benefits of protein restriction are worth the difficulty of sticking to a low protein diet. Although a reduced protein diet may delay dialysis for several years, the unappetizing nature of the diet is difficult for most people to tolerate. Speak to your healthcare provider about the advantages and disadvantages of a low protein diet. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/45/2777?source=see_link\">",
"      \"Protein restriction and progression of chronic kidney disease\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      High potassium",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people with chronic kidney disease develop a high blood potassium level, which can interfere with normal cell function. This is frequently treated with a diuretic. Measures to prevent high potassium might also be recommended, including a low potassium diet and avoiding medicines that raise potassium levels. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=see_link\">",
"      \"Patient information: Low potassium diet (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      High phosphate",
"     </span>",
"     &nbsp;&mdash;&nbsp;Phosphate is a mineral that helps to keep the bones healthy. Early in the course of chronic kidney disease, the body begins to retain phosphate. As the disease progresses, high blood phosphate levels can develop. This is usually treated with medicines that prevent phosphate (found in foods) from being absorbed in the digestive tract. Dietary phosphate restrictions are also recommended (",
"     <a class=\"graphic graphic_table graphicRef79877 graphicRef56081 \" href=\"UTD.htm?40/35/41530\">",
"      table 1A-B",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      High cholesterol and triglycerides",
"     </span>",
"     &nbsp;&mdash;&nbsp;High cholesterol and triglyceride levels are common in people with kidney disease. High triglycerides have been associated with an increased risk of coronary artery disease, which can lead to heart attack.",
"    </p>",
"    <p>",
"     Treatments to reduce the risk of coronary artery disease are usually recommended, including dietary changes, medications for high triglyceride and cholesterol levels, stopping smoking, and tight blood sugar control in people with diabetes. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=see_link\">",
"      \"Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      \"Patient information: Quitting smoking (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/43/39603?source=see_link\">",
"      \"Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Sexual function",
"     </span>",
"     &nbsp;&mdash;&nbsp;Men and women with advanced chronic kidney disease often have difficulties with sexual function and infertility. Over 50 percent of men with end-stage kidney disease have difficulties with erection and decreased sex drive. Women often have disturbances in the menstrual cycle and fertility, usually leading to a stop in menstrual periods. Decreased sex drive may also occur in women.",
"    </p>",
"    <p>",
"     You should discuss any changes in your sexual function with your healthcare provider because medications or other treatments may be effective. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"      \"Patient information: Sexual problems in men (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=see_link\">",
"      \"Patient information: Sexual problems in women (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;The risk that pregnancy will worsen kidney function, or that decreased kidney function will interfere with pregnancy depends upon a number of factors. A woman with mild to moderate chronic kidney disease who is considering becoming pregnant should discuss the possible risks with her nephrologist and obstetrical provider before trying to conceive.",
"    </p>",
"    <p>",
"     Women with end-stage kidney disease who are on dialysis and who become pregnant are at very high risk for miscarriage, premature delivery, severe hypertension, and preeclampsia. A woman who undergoes successful renal transplantation has a lower risk of these complications. It may be advantageous for a woman to delay becoming pregnant while on hemodialysis if renal transplantation in the near future is likely.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H21\">",
"     <span class=\"h1\">",
"      PREPARING FOR DIALYSIS",
"     </span>",
"    </p>",
"    <p>",
"     Some people with chronic kidney disease progressively worsen over time and will eventually need dialysis. There are two types of dialysis: hemodialysis and peritoneal dialysis. Kidney transplantation is also an option for some people with chronic kidney disease.",
"    </p>",
"    <p>",
"     An important component of treatment for patients with chronic kidney disease is planning for dialysis in advance. Although kidney transplantation is the treatment of choice in most cases, many people must wait months or years for a kidney to become available. Dialysis will likely be needed, often for an extended period.",
"    </p>",
"    <p>",
"     Dialysis and kidney transplantation are discussed in detail separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/26/9635?source=see_link\">",
"      \"Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=see_link\">",
"      \"Patient information: Hemodialysis (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/10/14501?source=see_link\">",
"      \"Patient information: Peritoneal dialysis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804390604\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5512852\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/35/28212?source=see_link\">",
"      Patient information: Chronic kidney disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21155?source=see_link\">",
"      Patient information: Swelling (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/40/36483?source=see_link\">",
"      Patient information: Diabetes and diet (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/44/35523?source=see_link\">",
"      Patient information: Polycystic kidney disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/1/25619?source=see_link\">",
"      Patient information: Hemodialysis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/22/11619?source=see_link\">",
"      Patient information: Preparing for hemodialysis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/47/15091?source=see_link\">",
"      Patient information: Preparing for pregnancy when you have diabetes (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=see_link\">",
"      Patient information: Peritoneal dialysis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/42/19107?source=see_link\">",
"      Patient information: Choosing between dialysis and kidney transplant (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/46/25315?source=see_link\">",
"      Patient information: Kidney transplant (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/15/12531?source=see_link\">",
"      Patient information: Planning for a kidney transplant (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/31/37363?source=see_link\">",
"      Patient information: Glomerular disease (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/59/9138?source=see_link\">",
"      Patient information: Polyarteritis nodosa (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/33/8722?source=see_link\">",
"      Patient information: Low-potassium diet (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/15/27889?source=see_link\">",
"      Patient information: Granulomatosis with polyangiitis (Wegener&rsquo;s) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/62/9188?source=see_link\">",
"      Patient information: Medicines for chronic kidney disease (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5512860\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/26/9635?source=see_link\">",
"      Patient information: Dialysis or kidney transplantation &mdash; which is right for me? (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/57/40852?source=see_link\">",
"      Patient information: Hemodialysis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=see_link\">",
"      Patient information: Glomerular disease overview (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/24/38277?source=see_link\">",
"      Patient information: Polycystic kidney disease (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/53/32594?source=see_link\">",
"      Patient information: Edema (swelling) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/35/15921?source=see_link\">",
"      Patient information: Protein in the urine (proteinuria) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/53/28499?source=see_link\">",
"      Patient information: Kidney stones in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/14/30944?source=see_link\">",
"      Patient information: Renal (kidney) biopsy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/32/37380?source=see_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/41/42640?source=see_link\">",
"      Patient information: Low potassium diet (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/4/6212?source=see_link\">",
"      Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/43/39603?source=see_link\">",
"      Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/33/29205?source=see_link\">",
"      Patient information: Sexual problems in men (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/4/12357?source=see_link\">",
"      Patient information: Sexual problems in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/10/14501?source=see_link\">",
"      Patient information: Peritoneal dialysis (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/18/41257?source=see_link\">",
"      Anemia of chronic kidney disease: Target hemoglobin/hematocrit for patients treated with erythropoietic agents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15399?source=see_link\">",
"      Assessment of nutritional status in end-stage renal disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28343?source=see_link\">",
"      Bone biopsy and the diagnosis of renal osteodystrophy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/31/34298?source=see_link\">",
"      Chronic kidney disease and coronary heart disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33559?source=see_link\">",
"      Clinical manifestations and diagnosis of coronary heart disease in end-stage renal disease (dialysis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/21/23896?source=see_link\">",
"      Darbepoetin alfa for the management of anemia in chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=see_link\">",
"      Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/32/521?source=see_link\">",
"      Epidemiology of chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=see_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15412?source=see_link\">",
"      Erythropoietin: Subcutaneous administration",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8436?source=see_link\">",
"      Hypertension following erythropoietin in chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4616?source=see_link\">",
"      Indications for initiation of dialysis in chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=see_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37434?source=see_link\">",
"      Overview of the management of chronic kidney disease in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41353?source=see_link\">",
"      Pathogenesis, consequences, and treatment of metabolic acidosis in chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/45/2777?source=see_link\">",
"      Protein restriction and progression of chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29703?source=see_link\">",
"      Risk factors and epidemiology of coronary artery disease in end-stage renal disease (dialysis)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/19/26938?source=see_link\">",
"      Secondary factors and progression of chronic kidney disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=see_link\">",
"      Urinalysis in the diagnosis of kidney disease",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.niddk.nih.gov/\">",
"      www.niddk.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Kidney Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(800) 922-9010",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.kidney.org/\">",
"      www.kidney.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       United Network for Organ Sharing (UNOS)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(888) 894-6361",
"     <br/>",
"     &nbsp; &nbsp; (",
"     <a class=\"external\" href=\"file://www.unos.org/\">",
"      www.unos.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Kidney Fund",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.kidneyfund.org/\">",
"      www.kidneyfund.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Association of Kidney Patients",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aakp.org/\">",
"      www.aakp.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?13/5/13398/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 14, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?13/5/13398?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13398/abstract/1\">",
"      Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13398/abstract/2\">",
"      Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13398/abstract/3\">",
"      Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13398/abstract/4\">",
"      Khan SS, Xue JL, Kazmi WH, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int 2005; 67:1038.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f13_5_13398=[""].join("\n");
var outline_f13_5_13398=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           CHRONIC KIDNEY DISEASE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           NORMAL KIDNEY FUNCTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CHRONIC KIDNEY DISEASE RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           CHRONIC KIDNEY DISEASE COMPLICATIONS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           EVALUATION AND DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           CHRONIC KIDNEY DISEASE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H21\">",
"           PREPARING FOR DIALYSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/35/3634\" title=\"figure 1\">",
"           Kidney anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/10/5286\" title=\"figure 2\">",
"           Nephron anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\" title=\"figure 3\">",
"           Urinary tract anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?0/21/346\" title=\"table 1A\">",
"           Phosphorus foods 1 PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?42/24/43400\" title=\"table 1B\">",
"           Phosphorus foods 2 PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f13_5_13399="Emergency airway management in the adult with direct airway trauma";
var content_f13_5_13399=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emergency airway management in the adult with direct airway trauma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Trevor J Mills, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Peter DeBlieux, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Ron M Walls, MD, FRCPC, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13399/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/5/13399/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway management in patients who have sustained direct trauma to the airway is among the most challenging problems for emergency clinicians. Blunt or penetrating injuries to the head, oropharynx, neck, or upper chest can result in immediate or delayed airway obstruction.",
"   </p>",
"   <p>",
"    Immediate, definitive airway management is needed when the patient cannot protect their airway or is unable to adequately oxygenate or ventilate. Emergent or urgent airway management is indicated when a patient develops respiratory distress or when symptoms are progressing rapidly. In addition, airway management often is indicated when the patient appears clinically stable, but the clinician anticipates clinical decline (eg, smoke inhalation, edema, subcutaneous air, hematoma) or feels that an unprotected airway presents a risk to the patient who requires transport to another facility or to radiology for extensive diagnostic studies. The higher rate of complicated airways in this population mandates that the clinician be prepared to use advanced airway techniques, including a surgical airway.",
"   </p>",
"   <p>",
"    Airway assessment and management in adults with direct airway trauma will be reviewed here. Other aspects of airway management, including a general approach to the difficult airway, the decision to intubate, and advanced tools for airway management, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=see_link\">",
"     \"Devices for difficult emergency airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=see_link\">",
"     \"The decision to intubate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The general management of trauma to the head and neck is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/49/7962?source=see_link\">",
"     \"Facial trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=see_link\">",
"     \"Penetrating neck injuries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3481?source=see_link\">",
"     \"Skull fractures in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES OF AIRWAY TRAUMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common causes of direct airway trauma include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blunt or penetrating maxillofacial injury",
"     </li>",
"     <li>",
"      Blunt or penetrating neck injury",
"     </li>",
"     <li>",
"      Smoke inhalation or facial burns",
"     </li>",
"     <li>",
"      Caustic ingestion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Face and neck injuries from blunt or penetrating trauma can cause severe bleeding into the oropharynx, expanding hematomas within soft tissue, and disruption of bone and soft tissue. Smoke inhalation, burns of the face and oropharynx, and caustic ingestions are all capable of causing mucosal injury and severe swelling and edema within the oropharynx, larynx, and tracheobronchial tree.",
"   </p>",
"   <p>",
"    It is crucial that emergency airway managers recognize that such injuries are dynamic and that conditions can deteriorate quickly. Hematomas and soft tissue swelling can expand rapidly, converting a partially obstructed airway into a completely obstructed airway.",
"   </p>",
"   <p>",
"    The general management of the injuries listed here is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/49/7962?source=see_link\">",
"     \"Facial trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=see_link\">",
"     \"Penetrating neck injuries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22790?source=see_link\">",
"     \"Smoke inhalation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=see_link\">",
"     \"Emergency care of moderate and severe thermal burns in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40551?source=see_link\">",
"     \"Caustic esophageal injury in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     AIRWAY ASSESSMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Determining the need for immediate intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in managing patients with direct airway trauma is to rapidly assess the patient and their airway to determine whether a definitive airway is needed emergently. Unresponsive patients and those with inadequate respiratory function are intubated during or immediately following evaluation. Patients in obvious respiratory distress also require prompt intubation. This includes patients struggling to breathe because of their injuries and those who have sustained severe burns of the face or who demonstrate blistering or edema of the oropharynx. Patients incapable of protecting their airway, as demonstrated, for example, by inability to clear debris from the oropharynx (eg, teeth, bone fragments, foreign bodies, emesis), also require prompt intubation.",
"   </p>",
"   <p>",
"    A simple assessment consisting of four basic questions often distinguishes patients requiring intubation from those who may be observed. An affirmative answer to any of the following questions identifies the need for intubation in nearly all scenarios involving direct airway trauma:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is there failure of airway maintenance or protection?",
"     </li>",
"     <li>",
"      Is there failure of ventilation?",
"     </li>",
"     <li>",
"      Is there failure of oxygenation?",
"     </li>",
"     <li>",
"      Is deterioration, particularly of the airway, anticipated? (ie, What is the expected clinical course?)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This approach to intubation and management of the failed airway is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=see_link\">",
"     \"The decision to intubate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Direct trauma to the airway can cause conditions that deteriorate precipitously leading to complete airway obstruction. Examples include expanding hematomas following blunt or penetrating trauma and soft tissue swelling following smoke inhalation or caustic ingestion. Of note, the progression of an airway injury, such as a soft tissue hematoma, may involve the deep tissue planes of the neck and therefore not become clinically apparent until airway obstruction is nearly complete and the chance for successful intervention is slim. Therefore, the risk of rapid airway compromise is a common and important reason for early intubation in patients with direct airway trauma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Signs of airway compromise",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with direct trauma to the face, neck, or upper chest who do not have a crash airway, the clinician performs a careful examination looking for signs of airway compromise. These signs may include any of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Direct signs of airway compromise:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Dyspnea",
"     </li>",
"     <li>",
"      Stridor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Indirect signs of airway compromise:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Drooling",
"     </li>",
"     <li>",
"      Trismus",
"     </li>",
"     <li>",
"      Painful swallowing (odynophagia)",
"     </li>",
"     <li>",
"      Tracheal deviation or other anatomical abnormality involving the larynx or trachea",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Signs of developing airway compromise:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Nonsuperficial burns of the face or neck",
"     </li>",
"     <li>",
"      Severe bleeding in the oropharynx or nasopharynx",
"     </li>",
"     <li>",
"      Subcutaneous air (crepitus) in the neck or upper chest",
"     </li>",
"     <li>",
"      Hematoma in the neck or lower face",
"     </li>",
"     <li>",
"      Hoarseness or other alterations in voice",
"     </li>",
"     <li>",
"      Subjective sense of shortness of breath despite adequate oxygen saturation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If any such signs are identified, it is generally prudent to secure the patient's airway early, before significant further deterioration occurs. Of note, the signs listed above may not be present during the clinician's initial examination. Frequent reexamination is needed in patients who have sustained significant direct trauma to the airway but whose airway is not secured early. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Patients appropriate for observation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A subset of initially stable patients is at higher risk of progressing to an unstable and potentially difficult airway. Patients with any of the following signs or conditions often require early intubation to prevent subsequent airway compromise or collapse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unstable mandible or midface injuries",
"     </li>",
"     <li>",
"      Steady bleeding into the oropharynx or nasopharynx",
"     </li>",
"     <li>",
"      Worsening or fluctuating level of consciousness",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Determining difficulty with management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergency clinicians should assess the patient's airway for potential difficulty with bag-mask ventilation, endotracheal intubation, rescue device placement, and cricothyrotomy. Mnemonics that can be used for these assessments are provided here and discussed in detail separately (",
"    <a class=\"graphic graphic_table graphicRef64336 \" href=\"UTD.htm?0/46/747\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73627 \" href=\"UTD.htm?0/39/635\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef67468 \" href=\"UTD.htm?2/49/2843\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef71383 \" href=\"UTD.htm?0/8/136\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13399/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Difficulty with bag-mask ventilation should be anticipated in patients who have sustained severe maxillofacial injuries that disrupt bones and create instability or disfigurement in the middle or lower face. Such injuries make it difficult to maintain a proper mask seal. Obstruction from heavy bleeding, soft tissue swelling, or hematoma can interfere with effective bag-mask ventilation. Posterior displacement of severe fractures of the maxilla or mandible can also obstruct the patient's airway [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13399/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subcutaneous air in the neck or communicating injury that establishes an external opening from any part of the airway (mouth, oropharynx, larynx, trachea) makes bag-mask ventilation impossible and also increases the likelihood that bag-mask ventilation will further distort anatomy, making subsequent airway rescue maneuvers more difficult.",
"   </p>",
"   <p>",
"    Bleeding and disruption of normal anatomy can make laryngoscopy and intubation extremely difficult. Mouth opening may be limited and should be carefully assessed with the anterior portion of the cervical collar removed. Bleeding, soft tissue swelling, and debris can obscure the view of the glottis during laryngoscopy, making effective suction essential.",
"   </p>",
"   <p>",
"    In-line stabilization of the neck is recommended in all blunt trauma patients during intubation, although it increases the difficulty of the procedure. In penetrating trauma, the role of in-line stabilization is controversial. Victims of isolated penetrating trauma who are neurologically intact rarely have unstable bony spinal columns and so are at low risk of sustaining a spinal cord injury during intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13399/abstract/3\">",
"     3",
"    </a>",
"    ]. However, a patient with penetrating injury may have concomitant blunt injury. Examples include a patient who is shot then falls down a flight of stairs or a patient who sustains a stab wound to the neck while also being beaten about the head and neck with blunt objects.",
"   </p>",
"   <p>",
"    Although in-line stabilization should be maintained if the clinician harbors any doubt about spinal column injury, the risk of unstable bony injury is so low in isolated penetrating injury with intact neurological examination that, if the operator is unable to see the glottis satisfactorily to intubate, it may be preferable to relax spinal immobilization somewhat to achieve a gentle intubation rather than allow hypoxemia to occur. Judgment is required to determine which of the two threats (hypoxemia caused by a failed airway versus spinal cord injury caused by spinal column movement) represents a more realistic or serious risk to the patient.",
"   </p>",
"   <p>",
"    Placement of a rescue device (eg, laryngeal mask airway) can be difficult if mouth opening is limited, if the airway is disrupted or distorted (eg, by swelling), or if debris such as teeth or bone fragments are present. Cricothyrotomy can be difficult if normal anatomic relationships are disrupted or a hematoma is present at the anterior neck.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Guiding principle: Secure the airway early",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries sustained from direct trauma to the airway are often dynamic and conditions can deteriorate quickly [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13399/abstract/4\">",
"     4",
"    </a>",
"    ]. As examples, hematomas and soft tissue swelling can expand rapidly, converting a partially obstructed airway into a completely obstructed airway. Signs suggestive of imminent obstruction are described above. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Signs of airway compromise'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    It is best to secure the airway early whenever signs of active or impending obstruction are identified or there is doubt about the extent of the injuries or their likely course. Doing so enables clinicians to secure the airway under relatively controlled circumstances before complete obstruction occurs and a crisis ensues.",
"   </p>",
"   <p>",
"    The basic and advanced techniques used to manage the airway are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=see_link\">",
"     \"Devices for difficult emergency airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Crash airway: No time available",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with direct trauma to their airway may present in extremis, unresponsive to the examiner and without effective ventilation or circulation (ie, crash airway). The basic approach to the crash airway remains unchanged in such patients. Algorithms outlining the basic approach to the traumatized airway and the crash airway are provided (",
"    <a class=\"graphic graphic_algorithm graphicRef75200 \" href=\"UTD.htm?23/41/24223\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef73509 \" href=\"UTD.htm?24/20/24910\">",
"     algorithm 2",
"    </a>",
"    ). The airway management algorithms are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=see_link\">",
"     \"Advanced emergency airway management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Management of the patient with an exposed trachea, most likely from a stab wound to the neck or a \"clothesline\" type injury, differs from the standard management of a crash airway. In such a circumstance, the airway manager prevents the inferior portion of the trachea from retracting into the chest by grasping it with a towel clip or clamp and the exposed trachea is then intubated directly. The general management of penetrating neck wounds is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=see_link\">",
"     \"Penetrating neck injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Time available and difficult airway anticipated",
"    </span>",
"    &nbsp;&mdash;&nbsp;The difficult airway algorithm&copy; provides the fundamental approach to the patient with direct airway trauma who requires intubation and whose airway is anticipated to be difficult (",
"    <a class=\"graphic graphic_algorithm graphicRef58510 \" href=\"UTD.htm?21/54/22382\">",
"     algorithm 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef75200 \" href=\"UTD.htm?23/41/24223\">",
"     algorithm 1",
"    </a>",
"    ). The specific approach selected is determined by the patient's injuries, patient attributes that suggest difficult airway management, the skills of the airway manager, and the resources available. The traumatized airway can be difficult to manage and it is important to obtain whatever help is available. The general approach to the difficult airway is discussed separately; aspects of management related to the traumatized airway are discussed below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most important questions to ask when faced with a traumatized airway (or any difficult airway) are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is there time? In other words, can the patient's oxygen saturation (SpO2) be maintained above 90 percent?",
"     </li>",
"     <li>",
"      Is difficulty with bag-mask ventilation (BMV) anticipated?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the SpO2 can be maintained above 90 percent, there is some time to consider different approaches and to make preparations. If adequate oxygenation cannot be maintained, a failed airway is present, and a definitive airway must be established promptly (",
"    <a class=\"graphic graphic_algorithm graphicRef73112 \" href=\"UTD.htm?12/9/12446\">",
"     algorithm 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the SpO2 remains above 90 percent and no risk factors for difficult BMV are identified, the clinician may elect to use standard rapid sequence intubation (RSI) to secure the airway. If difficult BMV is anticipated, RSI may pose risks, and an awake approach to intubation may be best.",
"   </p>",
"   <p>",
"    Alternatively, RSI may be undertaken using a \"double set-up\" in which the patient undergoes RSI with one or two brief attempts at laryngoscopy, proceeding directly to a cricothyrotomy if intubation is not possible. Both the intubation and the cricothyrotomy are prepared for in advance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note, subcutaneous emphysema usually represents a contraindication to BMV because gases forced into the airway during BMV can expand the neck's soft tissues, compromising subsequent efforts to ventilate or to intubate. In patients with very minimal detectable subcutaneous air, gentle, controlled bag-mask ventilation might be attempted, but its effectiveness is not assured and it should be abandoned if the subcutaneous air increases in volume.",
"   </p>",
"   <p>",
"    The awake approach to securing the airway involves sedation to the level used for common emergency department procedures (eg, using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    ) in conjunction with topical airway anesthesia (eg, using atomized or nebulized",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , or lidocaine paste or jelly). This approach allows the patient to continue to breathe spontaneously while sedation and topical anesthesia enable the clinician to overcome the patient's protective airway reflexes. Excessive blood or secretions in the airway limit the effectiveness of topical anesthetics and may preclude use of the awake approach if adequately deep sedation without topical anesthesia cannot be achieved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link&amp;anchor=H21#H21\">",
"     \"The difficult airway in adults\", section on 'Awake technique'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The awake but sedated patient can undergo standard direct laryngoscopy, video laryngoscopy, or fiberoptic laryngoscopy. The presence of a large amount of upper airway blood will likely make flexible fiberoptic laryngoscopy difficult or impossible. If the vocal cords are visualized, the clinician can opt to intubate during the awake look without additional medications or to withdraw the laryngoscope and perform standard RSI. We believe in general it is best not to remove the laryngoscope and perform RSI in a patient with direct airway trauma due to the risk of the glottic view deteriorating during the interim.",
"   </p>",
"   <p>",
"    Direct, fiberoptic, and video laryngoscopy are the primary awake intubation techniques used in the setting of the traumatized airway. Flexible fiberoptics require patient stability, time, and operator expertise. Rigid fiberoptic devices (eg, optical stylet) may enable clinicians to obtain a more rapid view of the glottis. Copious blood or secretions in the airway can make fiberoptic laryngoscopy difficult or impossible. Devices used for difficult airway management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=see_link\">",
"     \"Devices for difficult emergency airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some instances the clinician will judge RSI to be the best approach despite the presence of a potentially difficult airway, particularly if performed early before significant deterioration occurs (ie, when the anatomy is still close to normal). Several observational studies suggest that RSI is effective in patients with traumatized airways [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13399/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An approach incorporating a double set-up is often prudent when managing patients with traumatized airways, whether laryngoscopy is anticipated to be difficult or not. In this case, double set-up refers to simultaneous preparation for orotracheal intubation and cricothyrotomy. In other words, while medications and equipment are readied for RSI or an awake approach, the patient's neck is cleaned, landmarks identified, and a cricothyrotomy kit opened and prepared at the bedside. This enables the airway manager to shift instantly from an attempt at orotracheal intubation should a failed airway develop suddenly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=see_link\">",
"     \"Emergent surgical cricothyrotomy (cricothyroidotomy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some patients, a surgical airway may be the first and only choice for airway intervention. Severe injuries to the face, larynx, or supraglottic tissues may create an obstruction or an anatomic disruption that prevents the airway manager from gaining access to the glottis and performing orotracheal intubation. A surgical airway is also necessary in the patient with direct airway trauma that has an SpO2 below 90 percent despite optimal BMV, or in whom BMV cannot be performed. Of note, there is no absolute contraindication to cricothyrotomy in a patient who is dying of respiratory causes and who cannot be intubated orally.",
"   </p>",
"   <p>",
"    Supraglottic devices, such as the laryngeal mask airway (LMA), Combitube&trade;, and King LT&reg; airway, may be used as rescue techniques for the patient with direct airway trauma that can be effectively oxygenated by BMV. Such devices should not be used when a supraglottic airway obstruction exists, or when anatomy is significantly distorted.",
"   </p>",
"   <p>",
"    Blind passage of endotracheal tubes should NOT be attempted in patients with direct trauma to their airway because of the risk of exacerbating a preexisting injury. A surgical airway may be the best option in cases where the glottis cannot be seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Time available and difficult airway NOT anticipated",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with direct airway trauma who requires intubation and whose airway is NOT anticipated to be difficult is best managed by rapid sequence intubation (RSI). Assessment of the traumatized airway is discussed above, while the performance of RSI is discussed separately. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Airway assessment'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When preparing to perform definitive airway management in the apparently stable patient with direct airway trauma, the clinician must remain alert for signs of early or sudden airway compromise. Traumatized airways can deteriorate unexpectedly without obvious external signs of injury. Both basic and advanced equipment for difficult airway management, including a surgical airway, must be available at the bedside. In many cases, it is best to use a double set-up, in which preparations are made to perform RSI and the neck is prepared simultaneously for a surgical airway, with the cricothyrotomy kit open and prepared at the bedside. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=see_link\">",
"     \"Emergent surgical cricothyrotomy (cricothyroidotomy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Emergency clinicians should revert to the difficult airway management algorithm if signs of a potentially difficult airway manifest after the initial airway evaluation (",
"    <a class=\"graphic graphic_algorithm graphicRef58510 \" href=\"UTD.htm?21/54/22382\">",
"     algorithm 3",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Time available and difficult airway anticipated'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Patients appropriate for observation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the patient with direct airway trauma maintains normal vital signs, pulse oximetry, and mental status, and manifests none of the signs of impending airway compromise listed above, the patient is a candidate for observation. However, many patients who sustain direct airway trauma show no initial signs of airway instability but do show signs that suggest impending compromise. These patients need early definitive airway management. By securing the airway early, emergency clinicians avoid precipitant crises when immediate action is required to save the patient's life, the airway has become more difficult to manage, and equipment, medications, and personnel may not be ready. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Airway assessment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Some patients develop airway and breathing difficulties suddenly, despite the absence of external signs of airway compromise. Thus, all patients with direct airway trauma must be monitored closely, and the equipment necessary to place a definitive airway, including those necessary for a surgical airway, should be placed at the bedside. Early flexible fiberoptic examination of the upper airway is often advisable when the patient has minimal or no external signs of trauma, but there is evidence of internal injury, (eg, hoarseness).",
"   </p>",
"   <p>",
"    The monitoring and disposition of patients with direct airway trauma depends upon the nature and severity of injury. Most patients with airway trauma of any significance should remain in the ED or be admitted to a step down or intensive care unit overnight for monitoring. Observation should include frequent reassessment of pulse oximetry, voice quality, adequacy of respiration, swallowing, and bleeding in the airway, late developing hematoma, or any sign of worsening condition.",
"   </p>",
"   <p>",
"    If early fiberoptic examination reveals no internal injury and there is no external evidence of significant injury (eg, no hematoma, crepitus, or bruising) a shorter period of observation in the ED may suffice. There is no literature defining a sufficient period of observation in such cases, but we suggest a minimum of four hours. If the patient is intoxicated or otherwise displays an altered mental status, observation is continued until the mental status is normal and the patient can be reliably assessed. Again, observation is performed for a minimum of four hours following the injury.",
"   </p>",
"   <p>",
"    A subset of patients may undergo treatment in the ED that sufficiently stabilizes their injury such that the development of airway compromise becomes unlikely. Examples may include maxillary or alveolar ridge fractures that are immobilized by oral surgery, oropharyngeal lacerations that are repaired and show no further sign of hemorrhage or developing hematoma, and cases of minor smoke inhalation in whom upper airway endoscopy does not reveal significant edema or thermal injury.",
"   </p>",
"   <p>",
"    Following treatment and a brief period of observation (eg, four hours), such patients may be discharged with clear verbal and written instructions to return to the emergency department immediately for any concerns. A responsible adult should accompany such patients for approximately 24 hours following discharge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common causes of direct airway trauma include: blunt or penetrating maxillofacial injury, blunt or penetrating neck injury, smoke inhalation or facial burns, and caustic ingestion.",
"     </li>",
"     <li>",
"      The first step in managing patients with direct airway trauma is to determine whether the airway needs to be secured immediately or urgently. If this is not the case, clinicians then determine whether there are signs of impending airway compromise and possible difficulty with management. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Airway assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Injuries sustained from direct trauma to the airway are often dynamic and conditions can deteriorate quickly. It is best to secure the airway early whenever signs of active or impending obstruction are identified or there is doubt about the extent of the injuries or their likely course. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Guiding principle: Secure the airway early'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of the patient with direct airway trauma varies according to the time and resources available and the difficulties anticipated. An approach to each major scenario is described in the text. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Crash airway: No time available'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Time available and difficult airway anticipated'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Time available and difficult airway NOT anticipated'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with direct trauma to their airway may present in extremis, unresponsive and without effective ventilation or circulation (ie, crash airway). The basic approach to the crash airway remains unchanged in such patients. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Crash airway: No time available'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important questions to ask when faced with a traumatized airway are:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Is there time? In other words, can the patient's oxygen saturation (SpO2) be maintained above 90 percent?",
"     </li>",
"     <li>",
"      Is difficulty with bag-mask ventilation (BMV) anticipated?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the SpO2 can be maintained above 90 percent, there is some time to consider different approaches and to make preparations. If adequate oxygenation cannot be maintained, a failed airway is present and a definitive airway must be established promptly. If the SpO2 remains above 90 percent and no risk factors for difficult BMV are identified, the clinician may elect to use standard rapid sequence intubation (RSI) to secure the airway. If difficult BMV is anticipated, RSI may pose risks and intubation using an awake approach of \"double set-up\" (ie, simultaneous preparation for RSI and cricothyrotomy) may be best.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the patient with direct airway trauma maintains normal vital signs, pulse oximetry, and mental status, and manifests NONE of the signs of impending airway compromise listed above, the patient is a candidate for observation. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Patients appropriate for observation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Murphy MF, Walls RW. Identification of the difficult and failed airway. In: Manual of Emergency Airway Management, 3rd, Walls RM, Murphy MF.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13399/abstract/2\">",
"      Krausz AA, El-Naaj IA, Barak M. Maxillofacial trauma patient: coping with the difficult airway. World J Emerg Surg 2009; 4:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13399/abstract/3\">",
"      Connell RA, Graham CA, Munro PT. Is spinal immobilisation necessary for all patients sustaining isolated penetrating trauma? Injury 2003; 34:912.",
"     </a>",
"    </li>",
"    <li>",
"     Walls RW. Trauma. In: Manual of Emergency Airway Management, 3rd, Walls RW, Murphy MF.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13399/abstract/5\">",
"      Bair AE, Filbin MR, Kulkarni RG, Walls RM. The failed intubation attempt in the emergency department: analysis of prevalence, rescue techniques, and personnel. J Emerg Med 2002; 23:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13399/abstract/6\">",
"      Mandavia DP, Qualls S, Rokos I. Emergency airway management in penetrating neck injury. Ann Emerg Med 2000; 35:221.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 281 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-EBC78AF0D7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13399=[""].join("\n");
var outline_f13_5_13399=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES OF AIRWAY TRAUMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      AIRWAY ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Determining the need for immediate intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Signs of airway compromise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Determining difficulty with management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Guiding principle: Secure the airway early",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Crash airway: No time available",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Time available and difficult airway anticipated",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Time available and difficult airway NOT anticipated",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Patients appropriate for observation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/281\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/281|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?23/41/24223\" title=\"algorithm 1\">",
"      Traumatized airway management algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?24/20/24910\" title=\"algorithm 2\">",
"      Crash airway algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?21/54/22382\" title=\"algorithm 3\">",
"      Difficult airway algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?12/9/12446\" title=\"algorithm 4\">",
"      Failed airway algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/281|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/46/747\" title=\"table 1\">",
"      LEMON mnemonic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/39/635\" title=\"table 2\">",
"      MOANS mnemonic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/49/2843\" title=\"table 3\">",
"      SMART mnemonic for difficult cricothyrotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/8/136\" title=\"table 4\">",
"      RODS mnemonic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36068?source=related_link\">",
"      Advanced emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/38/40551?source=related_link\">",
"      Caustic esophageal injury in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/55/25466?source=related_link\">",
"      Devices for difficult emergency airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/50/4905?source=related_link\">",
"      Emergent surgical cricothyrotomy (cricothyroidotomy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/49/7962?source=related_link\">",
"      Facial trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/62/2026?source=related_link\">",
"      Penetrating neck injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3481?source=related_link\">",
"      Skull fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22790?source=related_link\">",
"      Smoke inhalation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=related_link\">",
"      The decision to intubate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=related_link\">",
"      The failed airway in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_5_13400="Crypto H and E";
var content_f13_5_13400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pleural biopsy with Cryptococcus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hematoxylin and eosin stain of a pleural biopsy specimen from a patient with cryptococcal pneumonia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Cartwright, E, Rouphael, N, Jain, S, Ilksoy, N. Pleural Effusion in a Patient with AIDS. Clin Infect Dis 2008; 46:1887. Copyright &copy;2008 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13400=[""].join("\n");
var outline_f13_5_13400=null;
var title_f13_5_13401="Prevention of type 1 diabetes mellitus";
var content_f13_5_13401=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of type 1 diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13401/contributors\">",
"     David K McCulloch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Massimo Pietropaolo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Irl B Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Joseph I Wolfsdorf, MB, BCh",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/5/13401/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/5/13401/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The increase in understanding of the pathogenesis of type 1 diabetes mellitus (formerly known as insulin-dependent diabetes mellitus) has made it possible to consider intervention to slow the autoimmune disease process in an attempt to delay or even prevent the onset of hyperglycemia. This topic will review current and planned efforts to prevent type 1 diabetes. Subjects who are at high risk for type 1 diabetes can be identified using a combination of immune, genetic, and metabolic markers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/21/32087?source=see_link\">",
"     \"Prediction of type 1 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the current classification of diabetes, immune mediated type 1 diabetes is called type 1A to distinguish it from less common cases in which an autoimmune etiology cannot be determined (type 1B); the latter are said to be idiopathic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/1\">",
"     1",
"    </a>",
"    ]. The term type 1 diabetes used here refers to type 1A, or autoimmune diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=see_link\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREVENTION AND REVERSAL STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several immunosuppressive and immunomodulatory agents and other drugs have been given either alone or in combination to decrease the immune-mediated destruction of beta-cells that occurs in type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/2\">",
"     2",
"    </a>",
"    ]. Most of the studies have been performed in recent onset diabetes where the majority of beta-cell function has already been lost, and the anticipated outcome is preservation of remaining beta-cell function, usually measured as area under the curve insulin secretion in response to stimulation. Many of the studies involve small numbers of patients and are uncontrolled.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Immunomodulators",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Azathioprine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     Azathioprine",
"    </a>",
"    is an immunosuppressive drug that inhibits or prevents T-cell responses to antigen. In one randomized, double-blind study of 46 patients treated with azathioprine and glucocorticoids, insulin could be discontinued in 10 of 20 treated patients, as compared with 2 of 20 patients in the placebo group [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/3\">",
"     3",
"    </a>",
"    ]. Endogenous insulin secretion (measured as the plasma C-peptide response to a liquid meal) also improved. However, only three treated patients remained in remission at one year. Equally discouraging results were noted in a second study [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Mycophenolate mofetil",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     Mycophenolate",
"    </a>",
"    mofetil (MMF, Cellcept) inhibits proliferation of both T- and B-lymphocytes. In a multicenter randomized trial, 126 patients with type 1 diabetes for less than three months were randomly assigned to MMF, MMF plus daclizumab (an anti-IL-2 receptor monoclonal antibody that selectively binds the IL-2 receptor, inhibiting IL-2 mediated T-lymphocyte proliferation) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/5\">",
"     5",
"    </a>",
"    ]. After two years, there was no significant difference in the mean area under the curve for C-peptide levels during a mixed-meal tolerance test. Thus, neither MMF alone or in combination with daclizumab slowed progression of beta-cell destruction in recently diagnosed type 1 diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large-scale trials in patients with recently diagnosed type 1 diabetes in Canada and France showed that remissions were twice as common in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    -treated patients, as compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/6\">",
"     6",
"    </a>",
"    ]. Although the remissions also lasted longer, almost all patients required insulin again within three years. An analysis of subjects recruited into the Canadian-European cyclosporine trial showed that subjects who were IA-2 negative at entry to the trial were more likely to respond to cyclosporine (with a decrease in insulin requirements and an increase in C-peptide secretion) than IA-2 positive subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Anti-CD3 antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of mice with an anti-CD3 monoclonal antibody (OKT3) reverses diabetes in nonobese diabetic (NOD) mice (a model in which spontaneous autoimmunity and pancreatic islet destruction occur) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/8\">",
"     8",
"    </a>",
"    ]. However, OKT3 use is problematic in humans because of significant cytokine-mediated (TNFa) side effects. Humanized monoclonal antibodies have been developed, which appear to have fewer major adverse effects (fever, headache, hypotension). These antibodies have been successfully used for the treatment of acute renal allograft rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/9\">",
"     9",
"    </a>",
"    ] and psoriatic arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism of action of this drug is not completely clear. Alterations in the number and function of regulatory T cells may contribute to the generation of an autoimmune state in type 1 diabetes. Dysfunction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    loss of CD1-restricted T cells, T cells with",
"    <span class=\"nowrap\">",
"     g/d",
"    </span>",
"    receptors,",
"    <span class=\"nowrap\">",
"     CD4+/CD25+",
"    </span>",
"    T cells and NKT cells may all theoretically contribute to disease pathogenesis through inefficient suppression of pathogenic autoreactive T cells. The antigens that activate regulatory T cells are unknown, and the mechanisms by which these cells exert their effect on immune responses remain unclear. It has been postulated that hOKT3g may affect the dynamics of regulatory T cell populations such as selective deletion of activated Th1 cells",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    activation of Th2 cells and their protective cytokines.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14924002\">",
"    <span class=\"h4\">",
"     Teplizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;A monoclonal antibody (mAb), termed hOKT3gl(Ala-Ala) (teplizumab), contains the binding region of OKT3 in which the CH2 region has been modified by site-directed mutagenesis to alter FcR-binding activity. In a study of patients with new-onset diabetes (less than six weeks since diagnosis) randomly assigned either to infusions of teplizumab for 14 days (using increasing doses) or no treatment, insulin production was maintained for one year in 9 of 12 patients in the treatment group and only 2 of 12 patients in the control group (p = 0.01) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/11\">",
"     11",
"    </a>",
"    ]. Hemoglobin A1C values and insulin doses were lower in the treatment group. Side effects, although reversible, included fever, anemia, and rash in most patients in the group that received anti-CD3 antibody.",
"   </p>",
"   <p>",
"    In a two-year trial, 516 patients (aged 8 to 35 years) with type 1 diabetes duration for &le;12 weeks were randomly assigned to receive one of three regimens of teplizumab (14 day full dose, 14 day low dose, or six day full dose) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/12\">",
"     12",
"    </a>",
"    ]. After one year, there was no difference in the primary composite outcome (percentage of patients with insulin use &lt;0.5",
"    <span class=\"nowrap\">",
"     Units/kg/day",
"    </span>",
"    and A1C &lt;6.5 percent) among the groups (19.8, 13.7, 20.8, and 20.4 percent, respectively). Change in area under the curve (AUC) for C-peptide from baseline (a secondary outcome) was similar among the four groups. In a predefined subgroup analysis, the reduction in median AUC of C-peptide was lower in actively treated patients who were 8 to 11 years of age and in patients who were randomized within six weeks of diagnosis. These preliminary findings suggest that teplizumab is most effective in preserving C-peptide secretion when administered early in the course of the disease. Additional trials targeting this patient population are needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14924010\">",
"    <span class=\"h4\">",
"     Otelixizumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Otelixizumab is another humanized monoclonal anti-CD3 antibody (ChAglyCD3). A multi-center trial included 80 patients with new-onset type 1 diabetes who were randomly assigned to otelixizumab for six consecutive days or placebo with the following results [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At 6, 12, and 18 months, residual beta-cell function, as assessed by glucose-clamp-induced C-peptide release before and after the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/32/25093?source=see_link\">",
"       glucagon",
"      </a>",
"      , was better maintained in the anti-CD3 antibody group.",
"     </li>",
"     <li>",
"      Insulin dose requirements increased in the placebo but not the treatment group.",
"     </li>",
"     <li>",
"      In the subgroup of patients with initial residual beta-cell function at or above the 50",
"      <sup>",
"       th",
"      </sup>",
"      percentile of the 80 patients, mean insulin dose at 18 months was 0.22 IU and 0.61",
"      <span class=\"nowrap\">",
"       IU/kg/day",
"      </span>",
"      in the treatment and placebo groups, respectively.",
"     </li>",
"     <li>",
"      Administration of anti-CD3 antibody was associated with significant but transient side effects including fever after the start of infusions, and rash and acute mononucleosis-like syndrome after the end of treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a follow-up report on 64 patients followed for a mean of 48 months, treatment for six days with otelixizumab appeared to have a durable effect [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/14\">",
"     14",
"    </a>",
"    ]. In the active treatment group, there was a delay in the rise in insulin requirements (+0.09 compared with +0.32",
"    <span class=\"nowrap\">",
"     Units/kg/day",
"    </span>",
"    in the placebo group).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Rituximab",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     Rituximab",
"    </a>",
"    , an anti-CD20 monoclonal antibody, has been used for the treatment of B-cell neoplasia and antibody-mediated autoimmune diseases, such as rheumatoid arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21130?source=see_link\">",
"     \"Rituximab and other B cell targeted therapies for rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is not well studied in autoimmune diseases that have a cell-mediated pathogenesis. However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    perhaps marks the beginning of new therapeutic strategies for type 1 diabetes, particularly if used in combination with insulin secretogogues",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other immunomodulatory agents. In a preliminary trial to determine its safety and efficacy in preserving C-peptide levels in 87 patients with new onset type 1 diabetes, the mean area under the curve for C-peptide levels during a mixed-meal tolerance test was significantly higher in the rituximab versus placebo group (0.56 versus 0.47",
"    <span class=\"nowrap\">",
"     pmol/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/15\">",
"     15",
"    </a>",
"    ]. More patients in the rituximab compared to the placebo group developed side effects (eg, fever, rash, pruritus, nausea, vomiting) after the first infusion. The reactions appeared to be minimal with subsequent infusions. There was no increase in infections or neutropenia with rituximab.",
"   </p>",
"   <p>",
"    The actual mechanism of the effect of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    in type 1 diabetes remains to be established. This drug may reduce the production of proinflammatory cytokines that enhance the immune response locally within the pancreas or the pancreatic lymph nodes. It is also possible that antigen presentation exerted by B lymphocytes, which is required for T-lymphocyte activation, is somehow affected by rituximab. Additional anti-B-lymphocyte agents, such as humanized anti-CD20 antibodies, should be tested in newly diagnosed type 1 diabetic patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21130?source=see_link&amp;anchor=H21#H21\">",
"     \"Rituximab and other B cell targeted therapies for rheumatoid arthritis\", section on 'Other B cell depleting agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Thymoglobulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thymoglobulin&reg; or antithymocyte globulin (ATG) is used in organ transplantation, but little is known about its potential beneficial effects in type 1 diabetes. Preclinical studies have shown that anti-lymphocyte serum treatment in NOD mice with recent onset diabetes can induce disease remission.",
"   </p>",
"   <p>",
"    In patients with newly diagnosed type 1 diabetes, equine ATG appeared to prolong the honeymoon phase of the disease. A phase II placebo-controlled trial is in progress; patients with newly diagnosed type 1 diabetes will be randomly assigned to rabbit polyclonal ATG (Thymoglobulin&reg; 6.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    administered over four days) or placebo. The primary end point will be the presence of residual endogenous insulin secretion at 12 month follow-up. The anticipated outcome is that the ATG group will have sustained endogenous insulin secretion and will exhibit a lower daily exogenous insulin requirement when compared to the control group. This study is supported by both The Immune Tolerance Network and TrialNet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Insulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;When given by injection in the prediabetic period to nonobese diabetic (NOD) mice and BB rats, insulin delays or prevents diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Insulin may act as an immunomodulator in these animals [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/16,18\">",
"     16,18",
"    </a>",
"    ]. Alternatively, it may allow the &szlig;-cells to rest and therefore become less vulnerable to further autoimmune attack because they express fewer autoantigens [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two observations in NOD mice provide support for an active immunomodulatory response:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunization of mice with intact insulin or its A or B chains does not reduce islet cell infiltration; however, immunization with insulin or its B chain is associated with both prevention of diabetes and a cellular infiltrate in which the content of interferon-gamma mRNA was reduced (",
"      <a class=\"graphic graphic_figure graphicRef81644 \" href=\"UTD.htm?25/36/26189\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/16\">",
"       16",
"      </a>",
"      ]. These observations suggest that insulin converts the insulitis from a destructive to a protective response [",
"      <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diabetes in mice can also be prevented by immunization with a metabolically inactive insulin analog [",
"      <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/21\">",
"       21",
"      </a>",
"      ]; this finding would not be expected if &szlig;-cell rest were an important protective mechanism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The possible rationale for insulin as an immunomodulator has come from studies in NOD mice demonstrating that an epitope on the insulin B chain is recognized by the diabetogenic infiltrating CD8+ T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H7#H7\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Insulin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It had been hoped that these findings would be applicable to humans. Two small studies suggested that insulin therapy might slow progression in patients with newly diagnosed type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/23\">",
"     23",
"    </a>",
"    ] or prevent diabetes in those at high risk (islet cell antibody-positive siblings of a diabetic proband), respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/21/32087?source=see_link\">",
"     \"Prediction of type 1 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, subsequent trials have not shown a benefit. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the Diabetes Prevention Trial, 339 patients at high risk for type 1 diabetes (siblings of diabetic patients with high serum islet-cell antibody concentrations and low acute insulin responses to glucose) were randomly assigned to receive close observation or low-dose subcutaneous insulin (ultralente insulin administered twice daily; total daily dose 0.25",
"      <span class=\"nowrap\">",
"       units/kg)",
"      </span>",
"      plus annual four-day continuous insulin infusions [",
"      <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/25\">",
"       25",
"      </a>",
"      ]. After median follow-up of 3.7 years, the cumulative incidence of diabetes was similar in the intervention and observation groups (42 versus 41 percent, respectively, hazard ratio [HR] 0.96, 95% CI 0.69-1.34) (",
"      <a class=\"graphic graphic_figure graphicRef62801 \" href=\"UTD.htm?7/51/7998\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In the same trial, 372 subjects at intermediate (rather than high) risk for type 1 diabetes were randomly assigned to oral insulin (7.5 mg daily) or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/26\">",
"       26",
"      </a>",
"      ]. Oral insulin was similarly ineffective in delaying or preventing type 1 diabetes (HR 0.76, 95% CI 0.51-1.14). However, in a subgroup analysis, a small beneficial effect of oral insulin administration in preventing type 1 diabetes was seen in subjects with confirmed high levels of IAA (&ge;80",
"      <span class=\"nowrap\">",
"       nU/mL).",
"      </span>",
"     </li>",
"     <li>",
"      In a Finnish trial of nasally-inhaled insulin in children with HLA-conferred risk for type 1 diabetes and high levels of at least two types of autoantibodies (islet cell, insulin, glutamic acid decarboxylase, protein tyrosine phosphatase-like protein), there was no difference in the onset of type 1 diabetes in those randomly assigned to intranasal insulin versus placebo (HR 1.14, 95% CI 0.73-1.77) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, administration of insulin at doses used in these trials did not delay or prevent the onset of type 1 diabetes in high-risk subjects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Immunotherapy DAB486-IL-2",
"    </span>",
"    &nbsp;&mdash;&nbsp;Future treatments may use specific immunotherapy targeted at the initiation of the autoimmune process (",
"    <a class=\"graphic graphic_figure graphicRef63541 \" href=\"UTD.htm?6/23/6527\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/2\">",
"     2",
"    </a>",
"    ]. One such study has begun in France [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/28\">",
"     28",
"    </a>",
"    ]. Prediabetic subjects are initially treated with seven daily infusions of DAB-IL2, a diphtheria toxin conjugated to part of the interleukin-2 molecule designed to target activated T cells; the infusions are followed by low doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    . It is hoped that the initial therapy with DAB-IL2 will slow the ongoing insulitis by destroying the activated T cells invading the islets and that the subsequent therapy with cyclosporine will maintain the remission.",
"   </p>",
"   <p>",
"    Another possible approach is aimed at the mechanisms by which cytotoxic T cells injure beta-cells. Studies in nonobese diabetic (NOD) mice suggest that cytokines secreted by islet-infiltrating mononuclear cells induce the expression of intercellular adhesion molecules (such as ICAM-1) on the beta-cells, which accelerates their destruction by cytotoxic T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/29\">",
"     29",
"    </a>",
"    ]. Interruption of this process by monoclonal antibodies against ICAM-1 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/29\">",
"     29",
"    </a>",
"    ] or perhaps by insulin [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/20\">",
"     20",
"    </a>",
"    ] could prevent the development of diabetes. Alternatively, the activated T cells involved in the destructive infiltrate could be specifically targeted for destruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     GAD65 immunotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glutamic acid decarboxylase, 65 kilodalton isoform (GAD65), is a major autoantigen in patients with type 1 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H8#H8\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Glutamic acid decarboxylase'",
"    </a>",
"    .) When administered by injection in the prediabetic period to nonobese diabetic (NOD) mice, disease progression was slowed [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/30\">",
"     30",
"    </a>",
"    ]. However, in a randomized trial of a vaccine formulation of recombinant human GAD65 (GAD-alum) or subcutaneous placebo (alum alone) in newly diagnosed (within 18 months) children and adolescents with type 1 diabetes, there was no difference in fasting C-peptide concentrations or insulin requirements after 15 months, despite the fact that vaccinated children demonstrated a GAD-specific immune response [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a similar trial, 145 patients (aged 3 to 45 years) diagnosed with type 1 diabetes within the past three months were randomly assigned to receive three doses of GAD-alum, two doses with a third placebo dose (alum alone), or three placebo doses [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/32\">",
"     32",
"    </a>",
"    ]. After one year, there was no difference in mean area under the curve of serum C-peptide concentration during a mixed meal tolerance test. In a second trial in which GAD-alum or placebo was administered to 334 patients within three months after diagnosis, stimulated C-peptide concentrations declined to a similar degree in both study groups at 15 month follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/33\">",
"     33",
"    </a>",
"    ]. Thus, earlier administration of alum-formulated GAD65 (3 versus 18 months after diagnosis) did not affect the primary outcome. Before autoantigen treatment is used, the dose, route, and regimen that could block antigen-specific pathogenic responses need to be better understood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H980995\">",
"    <span class=\"h3\">",
"     Costimulation modulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;T cell activation by antigen presenting cells requires two distinct signals. The first is binding of the T cell receptor-peptide-MHC II complex. The second signal is binding of cell surface costimulatory molecules (CD80 and CD86 on antigen presenting cells and CD 28 on T cells) that allow full activation of T cells.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"     Abatacept",
"    </a>",
"    (also called CTLA4-Ig) is a soluble fusion protein comprising cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and the Fc portion of IgG1. It prevents CD28 from binding to its counter-receptor,",
"    <span class=\"nowrap\">",
"     CD80/CD86,",
"    </span>",
"    due to its higher affinity for",
"    <span class=\"nowrap\">",
"     CD80/CD86.",
"    </span>",
"    Administration of CTLA4-Ig or successful transfer of its gene prevents full T cell activation. It ameliorates collagen-induced arthritis in mice and is beneficial in transplantation models. It is used for the treatment of rheumatoid arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/0/9223?source=see_link&amp;anchor=H5#H5\">",
"     \"T cell targeted therapies for rheumatoid arthritis\", section on 'Abatacept'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10682?source=see_link&amp;anchor=H12#H12\">",
"     \"Transplantation immunobiology\", section on 'T-cell costimulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Costimulation modulation with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    may block the production of autoaggressive T cells and thereby slow beta-cell destruction, as illustrated by the findings of a randomized trial in 112 patients (aged 6 to 45 years) with recently diagnosed type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/34\">",
"     34",
"    </a>",
"    ]. Patients were randomly assigned to receive abatacept (10",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    or placebo infusions (27 infusions over two years) within three months of diagnosis. After two years, the mean area under the curve for serum C-peptide concentration after a mixed meal was significantly higher in the abatacept group (0.378 versus 0.238",
"    <span class=\"nowrap\">",
"     nmol/L).",
"    </span>",
"    Abatacept delayed loss of beta-cell function for nine months, after which time the slope of the decrease in beta-cell function became similar to that in the placebo group. These findings suggest that T cell activation is still occurring at the time of clinical diagnosis, when abatacept was effective. However, continuing T cell activation subsides as the clinical course progresses, and abatacept is no longer effective.",
"   </p>",
"   <p>",
"    Longer-term follow-up is required to determine whether the improvement in beta-cell function is sustained after discontinuation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    . Until additional data are available, abatacept should not be used in clinical practice for the prevention of type 1 diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Bacillus Calmette-Guerin (BCG)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In view of the success of immunomodulation with Bacillus Calmette-Guerin (BCG) in NOD mice, BCG has been given in a pilot study to 17 newly diagnosed patients with type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/35\">",
"     35",
"    </a>",
"    ]. Eleven (65 percent) went into remission for up to 10 months. This success rate was significantly higher than in historical controls and there were no side effects.",
"   </p>",
"   <p>",
"    A larger trial randomly assigned 72 patients with new onset (less than four weeks) type 1 diabetes to therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/27/38322?source=see_link\">",
"     nicotinamide",
"    </a>",
"    alone or in combination with BCG [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/36\">",
"     36",
"    </a>",
"    ]. The number of patients in remission in each group was three at three months and none at 12 months. Nicotinamide-only therapy was subsequently reported to be an ineffective prevention therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Nicotinamide'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     DiaPep277",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 35 patients with type 1 diabetes and basal serum C-peptide concentrations &gt;0.1",
"    <span class=\"nowrap\">",
"     nmol/L,",
"    </span>",
"    DiaPep277, an immunomodulatory peptide derived from 60kDa heat shock protein, or placebo were given at zero, one, and six months. At 10 months, mean serum C-peptide concentrations were unchanged in the treatment group, but decreased in the placebo group, suggesting that endogenous insulin production was preserved in the treatment group [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Donor splenocytes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult nonobese diabetic (NOD) mice, characterized by spontaneous autoimmunity that causes diabetes via destruction of pancreatic islets, appear to contain endogenous precursor cells that can give rise to new islets if the underlying autoimmune disease is eliminated [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. This was demonstrated in a series of experiments in which injection of live donor splenocytes with Freund's adjuvant into NOD mice eliminated autoimmunity and resulted in the reappearance of pancreatic beta-cells, endogenous insulin secretion, and normoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/40\">",
"     40",
"    </a>",
"    ]. The new beta-cells had a Y chromosome, suggesting that they originated from the male donor splenocytes, rather than from the female recipient. In other experiments, injection of irradiated (not live) splenocytes also resulted in the appearance of new islets, suggesting that the new pancreatic islet cells can arise from endogenous precursor cells. In contrast, a second study in mice reported that pre-existing beta-cells rather than endogenous precursor cells are the major source of new beta-cells during adult life and after pancreatectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antiinflammatory",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     TNF-alpha inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumor necrosis factor-alpha (TNF-a) is a cytokine involved in the acute inflammatory process. It may play a role in the pathogenesis of beta-cell destruction in type 1 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute phase reactants\", section on 'Induction by cytokines'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"     Etanercept",
"    </a>",
"    is a recombinant TNF-alpha receptor that binds TNF-alpha and blocks its biologic activity. In a 24-week trial of etanercept versus placebo in 18 patients with newly diagnosed type 1 diabetes, patients assigned to etanercept had lower A1C values (5.9 versus 7.0 percent) and greater increases in C-peptide area under the curve (39 percent increase versus 20 percent decrease) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/42\">",
"     42",
"    </a>",
"    ]. Larger trials are required to assess the benefits and risks of etanercept for the prevention of type 1 diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Interferon alpha",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interferons are multifunctional immunomodulatory cytokines that may have effects upon the cytokine cascade, including several antiinflammatory properties. In a 12-month trial of oral human recombinant interferon alpha-2a (IF-a) versus placebo in 128 patients with newly diagnosed type 1 diabetes, patients randomly assigned to IF-a (5000 units daily) had a smaller percentage loss of mixed meal stimulated C-peptide (28 versus 56 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/43\">",
"     43",
"    </a>",
"    ]. However, there were no differences in A1C or insulin requirements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Supplements",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Nicotinamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;In animals,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/27/38322?source=see_link\">",
"     nicotinamide",
"    </a>",
"    has been found to protect beta-cells from chemical or autoimmune injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. It is thought to act as a free radical scavenger or by replenishing nicotinamide adenine dinucleotide, an essential coenzyme, within damaged cells, thereby promoting DNA repair and limiting DNA damage.",
"   </p>",
"   <p>",
"    Initial reports suggested clinical benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. A 1996 meta-analysis of 10 randomized trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/27/38322?source=see_link\">",
"     nicotinamide",
"    </a>",
"    in a total of 211 patients with newly diagnosed type 1 diabetes found that endogenous insulin production (measured by plasma C-peptide responses) was prolonged with nicotinamide administration, although no patient had a remission [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/27/38322?source=see_link\">",
"     nicotinamide",
"    </a>",
"    was ineffective in a large prevention trial. The Nicotinamide Diabetes Intervention Trial (ENDIT) studied 552 individuals ages 3 to 40 years with a first-degree relative with type 1 diabetes, positive islet-cell antibodies (&ge;20 Juvenile Diabetes Federation units), and non-diabetic glucose tolerance test; the subjects were randomly assigned to receive nicotinamide (1.2",
"    <span class=\"nowrap\">",
"     gm/m2",
"    </span>",
"    per day) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/37\">",
"     37",
"    </a>",
"    ]. After a mean follow-up of 3.3 years, the following results were seen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of developing diabetes was similar in the two groups: 82 of 274 (30 percent) and 77 of 275 (28 percent) in the treatment and placebo groups, respectively (HR 1.07).",
"     </li>",
"     <li>",
"      The results were the same after adjustment for age, oral glucose tolerance status, antibody status, and first phase insulin response on an intravenous glucose tolerance test.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Vitamin D supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although cow's milk may be associated with an increase of risk for type 1 diabetes, one component, vitamin D, may be protective. Support for this hypothesis comes from a case control study in seven European countries that suggested that supplementation with vitamin D in early infancy can protect against development of type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/48\">",
"     48",
"    </a>",
"    ]. A similar protective effect was noted in a birth-cohort study of over 10,000 children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/49\">",
"     49",
"    </a>",
"    ]. The children who regularly took vitamin D (2000 IU daily) had a reduced risk of type 1 diabetes compared with children whose vitamin D intake was less (RR 0.22).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Omega-3 polyunsaturated fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Omega-3 polyunsaturated fatty acids may have a modulating effect on the inflammatory response [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. A relative deficiency of omega-3 fatty acids, a characteristic of many Western diets, may predispose to enhanced inflammatory reactions, and therefore increase the risk of autoimmune diseases, such as type 1 diabetes. In one study, increased dietary intake of omega-3 fatty acids was associated with reduced risk of islet autoantibody responses in children at increased genetic risk for type 1 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H23#H23\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Omega-3 fatty acids'",
"    </a>",
"    .) A primary prevention trial of the effect of docosahexaenoic acid (an omega-3 fatty acid) on the natural history of type 1 diabetes is in progress [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4173418\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4173426\">",
"    <span class=\"h3\">",
"     Avoidance of cow's milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another approach is based upon the possible immunogenicity of the complex dietary proteins found in cow's milk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=see_link&amp;anchor=H20#H20\">",
"     \"Pathogenesis of type 1 diabetes mellitus\", section on 'Cow's milk'",
"    </a>",
"    .) In one trial, 230 breast-fed infants with HLA-conferred susceptibility to type 1 diabetes and at least one family member with type 1 diabetes were randomly assigned to supplementation with a casein hydrolysate formula or a conventional cow&rsquo;s milk-based formula [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/53\">",
"     53",
"    </a>",
"    ]. After 10 years of follow-up, at least one autoantibody developed in 17 and 33 children in the casein hydrolysate and cow&rsquo;s milk groups, respectively (17 versus 30 percent, adjusted HR 0.51, 95% CI 0.28-0.91). The cumulative incidence of islet cell and insulinoma-associated 2 molecule (IA-2) autoantibodies was significantly lower in the casein hydrolysate group. The development of type 1 diabetes, which was recorded but was not a primary endpoint of the trial, was similar between the two groups (6 versus 8 percent).",
"   </p>",
"   <p>",
"    The median age at time of supplementation with formula was older in the casein hydrolysate group (2.6 versus 1.1 months) and, therefore, the median duration of study-formula feeding was shorter in the casein hydrolysate group (3.3 versus 4.9 months). Thus, longer exposure to breast milk, rather than the composition of the supplemental formula, may account for the observed findings. A larger ongoing multinational trial of casein hydrolysate versus cow&rsquo;s milk, with power to assess progression to overt type 1 diabetes, should provide more definitive data [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Hematopoietic stem cell transplant",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proposed mechanism of action of hematopoietic stem cell transplantation is that it provides a period free from memory T cell influence, during which maturation of new lymphocyte progenitors can occur without recruitment to anti-self activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=see_link&amp;anchor=H16#H16\">",
"     \"The adaptive cellular immune response\", section on 'Memory T cells'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Allogeneic stem cell transplant (SCT) is used to treat malignant diseases. There is increasing interest in the use of SCT to treat autoimmune diseases, such as severe systemic lupus erythematosus, although experience is limited. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41578?source=see_link&amp;anchor=H19#H19\">",
"     \"Overview of the therapy and prognosis of systemic lupus erythematosus in adults\", section on 'Hematopoietic stem cell transplantation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study evaluated autologous nonmyeloablative stem cell transplantation in 15 patients (mean age 19.2 years) with recently diagnosed type 1 diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/55\">",
"     55",
"    </a>",
"    ]. Conditioning was achieved with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and antithymocyte globulin. Thirteen patients did not require exogenous insulin for 1 to 35 months (mean 14.8 months) in this uncontrolled trial. Peak stimulated C-peptide levels increased in 11 of 13 patients studied at six months and four of four studied at 24 months. In a follow-up evaluation (mean 29.8 months) that included eight additional patients, the improvement in C-peptide levels was sustained at 24 and 36 months after transplantation in patients in whom insulin therapy was either continuously (n = 12) or transiently (n = 8) discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?13/5/13401/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although beta-cell function appears to have improved, the study has several limitations. The major limitation of this study is the lack of a randomized control group that either received no intervention or received only immunosuppression or immunomodulation. Since newly diagnosed type 1 diabetes can be associated with a honeymoon period characterized by a reduction in insulin requirements, a control group is necessary. In addition, it is not clear what role the treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antithymocyte globulin may have played independent of the complete SCT procedure.",
"   </p>",
"   <p>",
"    Data on insulin and IA-2 autoantibodies, two major markers currently used to confirm the diagnosis of type 1A diabetes and to predict type 1 diabetes, are not provided. The presence of at least three autoantibody markers (GAD65, IA-2, and insulin autoantibodies) should be required for enrollment in a SCT trial. The study is also limited by small size, short duration of follow-up, and side effects of the procedure, including febrile neutropenia, nausea, vomiting, and alopecia. Pneumonia occurred in two individuals and premature ovarian failure in one. Thus, it is unclear if SCT has a role in the",
"    <span class=\"nowrap\">",
"     treatment/reversal",
"    </span>",
"    of newly diagnosed type 1 diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=see_link\">",
"       \"Patient information: Type 1 diabetes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/26/36259?source=see_link\">",
"       \"Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the prevention of type 1 diabetes is still at the stage of research trials, the trials are often mentioned in the lay press. As a result, many patients with type 1 diabetes (or their parents) ask their doctors about screening of other family members (particularly children) and what could be done if the family member has a high risk for the development of type 1 diabetes. The approach to screening individuals at risk for type 1 diabetes is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/21/32087?source=see_link\">",
"     \"Prediction of type 1 diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a research setting, the following evaluation may be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Test individuals at risk for type 1 diabetes progression for GAD65, IA-2 autoantibodies.",
"     </li>",
"     <li>",
"      If they are present and confirmed in a subsequent sample, tests for insulin, zinc transporter (ZnT8), and islet cell antibodies can be done and the first phase insulin response to glucose determined.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The occurrence of multiple antibodies against islet autoantigens serves as a surrogate marker of disease in primary or secondary intervention strategies aimed at halting the disease process.",
"   </p>",
"   <p>",
"    Genetic typing for susceptibility or protective HLA alleles can also be performed. In the aggregate, this information can be used to ascertain if a high-risk subject is eligible to be entered into an ongoing prevention trial, but is not recommended in routine clinical practice.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/1\">",
"      Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/2\">",
"      Skyler JS. Prediction and prevention of type 1 diabetes: progress, problems, and prospects. Clin Pharmacol Ther 2007; 81:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/3\">",
"      Silverstein J, Maclaren N, Riley W, et al. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 1988; 319:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/4\">",
"      Cook JJ, Hudson I, Harrison LC, et al. Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes 1989; 38:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/5\">",
"      Gottlieb PA, Quinlan S, Krause-Steinrauf H, et al. Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes. Diabetes Care 2010; 33:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/6\">",
"      Bougn&egrave;res PF, Landais P, Boisson C, et al. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes 1990; 39:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/7\">",
"      Christie MR, M&oslash;lvig J, Hawkes CJ, et al. IA-2 antibody-negative status predicts remission and recovery of C-peptide levels in type 1 diabetic patients treated with cyclosporin. Diabetes Care 2002; 25:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/8\">",
"      Chatenoud L, Thervet E, Primo J, Bach JF. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 1994; 91:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/9\">",
"      Woodle ES, Xu D, Zivin RA, et al. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 1999; 68:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/10\">",
"      Utset TO, Auger JA, Peace D, et al. Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol 2002; 29:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/11\">",
"      Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346:1692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/12\">",
"      Sherry N, Hagopian W, Ludvigsson J, et al. Teplizumab for treatment of type 1 diabetes (Prot&eacute;g&eacute; study): 1-year results from a randomised, placebo-controlled trial. Lancet 2011; 378:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/13\">",
"      Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352:2598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/14\">",
"      Keymeulen B, Walter M, Mathieu C, et al. Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia 2010; 53:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/15\">",
"      Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361:2143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/16\">",
"      Muir A, Peck A, Clare-Salzler M, et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 1995; 95:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/17\">",
"      Vlahos WD, Seemayer TA, Yale JF. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 1991; 40:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/18\">",
"      Peakman M, Hussain MJ, Millward BA, et al. Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes. Diabet Med 1990; 7:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/19\">",
"      Aaen K, Rygaard J, Josefsen K, et al. Dependence of antigen expression on functional state of beta-cells. Diabetes 1990; 39:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/20\">",
"      Gladstone P, Nepom GT. The prevention of IDDM. Injecting insulin into the cytokine network. Diabetes 1995; 44:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/21\">",
"      Karounos DG, Bryson JS, Cohen DA. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J Clin Invest 1997; 100:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/22\">",
"      Wong FS, Karttunen J, Dumont C, et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 1999; 5:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/23\">",
"      Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N Engl J Med 1989; 320:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/24\">",
"      Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 1993; 341:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/25\">",
"      Diabetes Prevention Trial--Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/26\">",
"      Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. Diabetes Care 2005; 28:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/27\">",
"      N&auml;nt&ouml;-Salonen K, Kupila A, Simell S, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008; 372:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/28\">",
"      Boitard, C, Timsit, J, Assan, R, et al. Treatment of type 1 diabetes mellitus with DAB486-IL-2, a toxin conjugate which targets activated T-lymphocytes. Diabetologia 1992; 35:A218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/29\">",
"      Yagi N, Yokono K, Amano K, et al. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 1995; 44:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/30\">",
"      Tisch R, Liblau RS, Yang XD, et al. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 1998; 47:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/31\">",
"      Ludvigsson J, Faresj&ouml; M, Hjorth M, et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008; 359:1909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/32\">",
"      Wherrett DK, Bundy B, Becker DJ, et al. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet 2011; 378:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/33\">",
"      Ludvigsson J, Krisky D, Casas R, et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med 2012; 366:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/34\">",
"      Orban T, Bundy B, Becker DJ, et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 378:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/35\">",
"      Shehadeh N, Calcinaro F, Bradley BJ, et al. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 1994; 343:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/36\">",
"      Pozzilli P. BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group. Lancet 1997; 349:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/37\">",
"      Gale EA, Bingley PJ, Emmett CL, et al. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004; 363:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/38\">",
"      Raz I, Elias D, Avron A, et al. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001; 358:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/39\">",
"      Ryu S, Kodama S, Ryu K, et al. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest 2001; 108:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/40\">",
"      Kodama S, K&uuml;htreiber W, Fujimura S, et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003; 302:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/41\">",
"      Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/42\">",
"      Mastrandrea L, Yu J, Behrens T, et al. Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 2009; 32:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/43\">",
"      Rother KI, Brown RJ, Morales MM, et al. Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes. Diabetes Care 2009; 32:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/44\">",
"      LeDoux SP, Hall CR, Forbes PM, et al. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 1988; 37:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/45\">",
"      Yamada K, Nonaka K, Hanafusa T, et al. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice. Diabetes 1982; 31:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/46\">",
"      Pozzilli P, Browne PD, Kolb H. Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The Nicotinamide Trialists. Diabetes Care 1996; 19:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/47\">",
"      Elliott RB, Chase HP. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 1991; 34:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/48\">",
"      Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999; 42:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/49\">",
"      Hypp&ouml;nen E, L&auml;&auml;r&auml; E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/50\">",
"      Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001; 36:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/51\">",
"      De Caterina R, Madonna R, Massaro M. Effects of omega-3 fatty acids on cytokines and adhesion molecules. Curr Atheroscler Rep 2004; 6:485.",
"     </a>",
"    </li>",
"    <li>",
"     ClinicalTrials.gov - A service of the US National Institutes of Health file://www.clinicaltrials.gov (Accessed on July 21, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/53\">",
"      Knip M, Virtanen SM, Sepp&auml; K, et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010; 363:1900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/54\">",
"      TRIGR Study Group. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 2007; 8:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/55\">",
"      Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297:1568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/5/13401/abstract/56\">",
"      Couri CE, Oliveira MC, Stracieri AB, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301:1573.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1811 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-D7E3B57AC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13401=[""].join("\n");
var outline_f13_5_13401=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREVENTION AND REVERSAL STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Immunomodulators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Azathioprine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Mycophenolate mofetil",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Anti-CD3 antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H14924002\">",
"      Teplizumab",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H14924010\">",
"      Otelixizumab",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Rituximab",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Thymoglobulin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Insulin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Immunotherapy DAB486-IL-2",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - GAD65 immunotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H980995\">",
"      - Costimulation modulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Bacillus Calmette-Guerin (BCG)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - DiaPep277",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Donor splenocytes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antiinflammatory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - TNF-alpha inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Interferon alpha",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Nicotinamide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Vitamin D supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Omega-3 polyunsaturated fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4173418\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4173426\">",
"      - Avoidance of cow's milk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Hematopoietic stem cell transplant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/1811\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/1811|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/36/26189\" title=\"figure 1\">",
"      Insulin benefit in NOD mouse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/51/7998\" title=\"figure 2\">",
"      Insulin relatives at risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/23/6527\" title=\"figure 3\">",
"      Antigen presentation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=related_link\">",
"      Acute phase reactants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=related_link\">",
"      Classification of diabetes mellitus and genetic diabetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/38/41578?source=related_link\">",
"      Overview of the therapy and prognosis of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/42/23210?source=related_link\">",
"      Pathogenesis of type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/26/36259?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=related_link\">",
"      Patient information: Type 1 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/21/32087?source=related_link\">",
"      Prediction of type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21130?source=related_link\">",
"      Rituximab and other B cell targeted therapies for rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/0/9223?source=related_link\">",
"      T cell targeted therapies for rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=related_link\">",
"      The adaptive cellular immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10682?source=related_link\">",
"      Transplantation immunobiology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_5_13402="Eclipse nevus";
var content_f13_5_13402=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73770%7EDERM%2F53622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73770%7EDERM%2F53622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eclipse nevus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A compound nevus on the scalp of a child showing a light brown center and a more intensely pigmented rim.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Eclipse nevus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A compound nevus on the scalp of a child showing a light brown center and a more intensely pigmented rim.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13402=[""].join("\n");
var outline_f13_5_13402=null;
var title_f13_5_13403="Complications of pulmonary AVM";
var content_f13_5_13403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Complications of pulmonary AVMs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Seizure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Migraine headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transient ischemic attack",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebrovascular accident",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brain abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoxemia/orthodeoxia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exercise intolerance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemothorax",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemoptysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Catamennial hemoptysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Polycythemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infectious endocarditis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13403=[""].join("\n");
var outline_f13_5_13403=null;
var title_f13_5_13404="Pediatric signs of dehydration";
var content_f13_5_13404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Physical findings of volume depletion in infants and children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Finding",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mild (3-5 percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Moderate (6-9 percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severe (&ge;10 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulse",
"       </td>",
"       <td>",
"        Full, normal rate",
"       </td>",
"       <td>",
"        Rapid",
"       </td>",
"       <td>",
"        Rapid and weak OR absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systolic pressure",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal to low",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respirations",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Deep, rate may be increased",
"       </td>",
"       <td>",
"        Deep, tachypnea OR decreased to absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Buccal mucosa",
"       </td>",
"       <td>",
"        Tacky or slightly dry",
"       </td>",
"       <td>",
"        Dry",
"       </td>",
"       <td>",
"        Parched",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anterior fontanelle",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Sunken",
"       </td>",
"       <td>",
"        Markedly sunken",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eyes",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Sunken",
"       </td>",
"       <td>",
"        Markedly sunken",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin turgor",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Reduced",
"       </td>",
"       <td>",
"        Tenting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Cool",
"       </td>",
"       <td>",
"        Cool, mottled, acrocyanosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Urine output",
"       </td>",
"       <td>",
"        Normal or mildly reduced",
"       </td>",
"       <td>",
"        Markedly reduced",
"       </td>",
"       <td>",
"        Anuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic signs",
"       </td>",
"       <td>",
"        Increased thirst",
"       </td>",
"       <td>",
"        Listlessness, irritability",
"       </td>",
"       <td>",
"        Grunting, lethargy, coma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13404=[""].join("\n");
var outline_f13_5_13404=null;
var title_f13_5_13405="Markers of risk in HCM";
var content_f13_5_13405=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The recognised markers of risk in HCM and their sensitivity, specificity, positive and negative predictive accuracy (PPA and NPA)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Risk factor",
"      </td>",
"      <td class=\"subtitle1\">",
"       Sensitivity, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Specificity, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       PPA, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       NPA, percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Abnormal blood pressure response: &lt;40 years old",
"       <sup>",
"        [1]",
"       </sup>",
"      </td>",
"      <td>",
"       75",
"      </td>",
"      <td>",
"       66",
"      </td>",
"      <td>",
"       15",
"      </td>",
"      <td>",
"       97",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NSVT: adult &lt;45 years old",
"       <sup>",
"        [2]",
"       </sup>",
"      </td>",
"      <td>",
"       69",
"      </td>",
"      <td>",
"       80",
"      </td>",
"      <td>",
"       22",
"      </td>",
"      <td>",
"       97",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NSVT: &le;21 years old",
"       <sup>",
"        [3]",
"       </sup>",
"      </td>",
"      <td>",
"       &lt;10",
"      </td>",
"      <td>",
"       89",
"      </td>",
"      <td>",
"       &lt;10",
"      </td>",
"      <td>",
"       85",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Inducible VT/VF: high risk population",
"       <sup>",
"        [4]",
"       </sup>",
"      </td>",
"      <td>",
"       82",
"      </td>",
"      <td>",
"       68",
"      </td>",
"      <td>",
"       17",
"      </td>",
"      <td>",
"       98",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Syncope: &lt;45 years old",
"       <sup>",
"        [5]",
"       </sup>",
"       *",
"      </td>",
"      <td>",
"       35",
"      </td>",
"      <td>",
"       82",
"      </td>",
"      <td>",
"       25",
"      </td>",
"      <td>",
"       86",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Family history: at least one unexplained sudden death &plusmn; HCM",
"       <sup>",
"        [5]",
"       </sup>",
"       *",
"      </td>",
"      <td>",
"       42",
"      </td>",
"      <td>",
"       79",
"      </td>",
"      <td>",
"       28",
"      </td>",
"      <td>",
"       88",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LVH &ge;3 cm",
"       <sup>",
"        [6]",
"       </sup>",
"       &bull;",
"      </td>",
"      <td>",
"       26",
"      </td>",
"      <td>",
"       88",
"      </td>",
"      <td>",
"       13",
"      </td>",
"      <td>",
"       95",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Two or more risk factors",
"       <sup>",
"        [7]",
"       </sup>",
"       &bull;&Delta;",
"      </td>",
"      <td>",
"       45",
"      </td>",
"      <td>",
"       90",
"      </td>",
"      <td>",
"       23",
"      </td>",
"      <td>",
"       96",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LVH: left ventricular hypertrophy; NSVT: non-sustained ventricular tachycardia; VF: ventricular fibrillation; VT: ventricular tachycardia.",
"     <br>",
"      * Figures provided are for the risk of death from all causes rather than sudden death only.",
"      <br>",
"       &bull; Figures provided are for risk of sudden death and/or appropriate ICD discharge.",
"       <br>",
"        &Delta; In this data set from Elliott and colleagues, family history and syncope were combined in order to achieve statistical significance of relative risk.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     1. McKenna, WJ, Franklin, RC, Nihoyannopoulos, P, et al. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 1988; 11:147.",
"     <br>",
"      2. Maron, BJ, Savage, DD, Wolfson, JK, et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981; 48:252.",
"      <br>",
"       3. McKenna, WJ, Oakley, CM, Krikler, DM, et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985; 53:412.",
"       <br>",
"        4. Fananapazir, L, Chang, AC, Epstein, SE, McAreavey, D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992; 86:730.",
"        <br>",
"         5. McKenna, W, Deanfield, J, Faruqui, A, et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47:532.",
"         <br>",
"          6. Elliott, PM, Gimeno, BJ, Mahon, NG, et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001; 357:420.",
"          <br>",
"           7. Elliott, PM, Poloniecki, J, Dickie, S, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000; 36:2212.",
"           <br>",
"            Reproduced with permission from: McKenna, WJ, Behr, ER. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart 2002; 87:169. Copyright &copy; 2002 BMJ Publishing Group, Ltd.",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13405=[""].join("\n");
var outline_f13_5_13405=null;
var title_f13_5_13406="Gemcitabine and cisplatin for metastatic urothelial cancer";
var content_f13_5_13406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Gemcitabine and cisplatin (GC) for metastatic urothelial cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        <p>",
"         Cycle length: 28 days.",
"        </p>",
"        Total cycles: 6 (maximum)*.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Gemcitabine",
"        </strong>",
"       </td>",
"       <td>",
"        1000 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 100 mL normal saline (NS) (concentration no more than 40 mg/mL) and administer over 30 to 60 minutes.",
"       </td>",
"       <td>",
"        Days 1, 8, and 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cisplatin",
"        </strong>",
"       </td>",
"       <td>",
"        70 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL NS and administer over two hours. Do not administer with aluminum needles or sets.",
"       </td>",
"       <td>",
"        Day 2*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        Induction of diuresis using intravenous NS minimizes the risk of cisplatin nephrotoxicity. Fluid administration should be adequate to establish a urine flow of at least 100 mL/hour for two hours prior to and two hours after cisplatin administration. There are a number of alternative hydration regimens. One approach is to administer 1 liter of NS over two to three hours prior to cisplatin administration and a minimum of 500 mL either with or following the cisplatin administration. Supplementation with magnesium and potassium may be required depending upon the serum electrolytes. Some centers give mannitol (12.5 gm) with the cisplatin to encourage diuresis. The addition of furosemide is generally not required unless there is evidence of fluid overload or insufficient urine output. Refer to UpToDate topic on \"Cisplatin nephrotoxicity\", section on Prevention.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (greater than 90 percent frequency of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Cisplatin is an irritant at low concentrations (less than 0.5 mg/mL) but can cause necrosis at higher concentrations if infiltrated subcutaneously",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Not applicable.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for preexisting baseline renal or liver dysfunction:",
"        </strong>",
"        Dose reductions are required for cisplatin in renal insufficiency. It is recommended that the cisplatin dose be reduced by 25 percent for creatinine clearance 10 to 50 mL/min and 50 percent for creatinine clearance less than 10 mL/min. There are no published studies to guide dosing in patients with liver dysfunction. There is conflicting evidence about the need for dose reduction of gemcitabine in patients with preexisting hepatic dysfunction. Specific dosing guidelines for patients with hepatic insufficiency are not provided in the US FDA-approved manufacturer's product labeling, but a reduction of at least 20 percent is prudent for patients with hyperbilirubinemia",
"        <sup>",
"         [3]",
"        </sup>",
"        . Although patients with elevated creatinine levels may have greater than expected toxicity from gemcitabine, even at reduced doses, a dose modification scheme based upon renal dysfunction has not been developed. The FDA-approved labeling states only that gemcitabine should be administered with caution in patients with evidence of significant renal dysfunction. Refer to UpToDate topics on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\" and \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess electrolytes, renal, and liver function weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Each cycle should not begin until the WBC is greater than 3000/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelet count is greater than 100,000/mm",
"        <sup>",
"         3[1]",
"        </sup>",
"        . Gemcitabine should be withheld on day 8 and/or day 15 of the scheduled treatment if the WBC is less than 2000/mm",
"        <sup>",
"         3",
"        </sup>",
"        or the platelet count is less than 50,000/mm",
"        <sup>",
"         3[1]",
"        </sup>",
"        . If the day 8 or 15 dose of gemcitabine is omitted, the treatment cycle may be shortened to 21 days. This is consistent with the US FDA-approved product information to hold gemcitabine for an ANC less than 500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelets less than 50,000 cells/mm",
"        <sup>",
"         3[3]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurologic toxicity:",
"        </strong>",
"        Neuropathy usually is seen with cumulative doses of cisplatin &gt;400 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        , although there is marked interindividual variation. Patients with mild neuropathy can continue to receive full cisplatin doses. However, if the neuropathy interferes with function, the risk of potentially disabling neurotoxicity must be weighed against the benefit of continued treatment. Refer to UpToDate topic on \"Neurologic complications of platinum-based chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for renal dysfunction:",
"        </strong>",
"        It is recommended that subsequent doses of cisplatin be withheld until the serum creatinine is less than 1.5 mg/dL and/or BUN is less than 25 mg/dL",
"        <sup>",
"         [2]",
"        </sup>",
"        . Gemcitabine has been associated with renal failure and microangiopathic hemolytic anemia (thrombotic thrombocytopenic purpura/hemolytic uremic syndrome). Drug discontinuation is recommended if this occurs.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, doses should be recalculated for all drugs.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; CBC: complete blood count; WBC: white blood cell count; ANC: absolute neutrophil count; BUN: blood urea nitrogen.",
"     <br/>",
"     * An alternative regimen uses a three-week cycle consisting of gemcitabine (1200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ) on days 1 and 8 and cisplatin (75 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ) on day 2 for a maximum of six cycles",
"     <sup>",
"      [4]",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       van der Maase H, et al. J Clin Oncol 2000; 17:3068.",
"      </li>",
"      <li>",
"       Platinol (cisplatin) injection, powder, lyophilized, for solution. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 13, 2011).",
"      </li>",
"      <li>",
"       Gemzar (gemcitabine hydrochloride) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 13, 2011).",
"      </li>",
"      <li>",
"       Adamo V, et al. Oncology 2005; 69:391.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13406=[""].join("\n");
var outline_f13_5_13406=null;
var title_f13_5_13407="TPMT testing II";
var content_f13_5_13407=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    A suggested approach for the initiation of therapy with azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 462px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TPMT: thiopurine methyltransferase; AZA: azathioprine; 6-MP: 6-mercaptopurine.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Lichtenstein, GR. Use of laboratory testing to guide 6-mercaptopurine azathioprine therapy. Gastroenterology 2004; 127:1558. Copyright &copy; 2004 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_5_13407=[""].join("\n");
var outline_f13_5_13407=null;
